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2. Executive summary 
 
Science, technology and innovation (STI) is the driver for economic growth and development, 
and is currently at the heart of development discussions in Eastern Africa. Governments in the 
region are increasingly seeking ways to harness the potential of STI to boost economic growth, 
alleviate poverty and ensure environmental sustainability. This resurging interest in promoting 
science and technology for growth may be an opportunity for the region to grasp; and the 
momentum it is creating should be directed and focused on strategic development priorities for 
the region. Arguably this strategic direction could be in prioritizing biosciences as it is an area 
the region could have a competitive edge given its rich natural resources(especially biodiversity), 
and the growing global demand for bio-based products and services. Programmes such as 
BioInnovate are, therefore, well suited to catalyze growth in this direction. Moving forward, it is 
important to identify demand for specific biosciences and related technologies, and forge the 
essential links necessary to bring them to market. The Bioscience Innovation Policy Consortium 
for Eastern Africa (BIPCEA) will make a contribution to this end.  
 
With increasing expectations from the biosciences, there are also growing demands on public 
research organizations to create and catalyze the development of pro-poor, demand-driven 
innovations. However, public organizations in Eastern Africa are often ill-equipped to move 
innovations beyond the initial research stages and meaningfully partner with the private sector in 
product development and dissemination. The BIPCEA comes in handy with the goal of 
providing policy support services which are necessary to move research ideas and products to the 
market, and ultimately lead to a vibrant bio-economy in Eastern Africa. It is expected that 
through this project Bio-Innovate partner organizations will increasingly be able to develop and 
commercialize their bioscience innovations; and that policies, strategies and plans to promote 
bioscience innovations generally will be more prominent in the policy and development agenda 
in Eastern Africa. 
 
A key question for the project is to establish the extent to which BioInnovate partner 
organizations can play leading roles in advancing bioscience innovations for socio-economic 
development of Eastern Africa; and also examine what specifically would be required from them 
to play a catalytic role in the innovation process. These issues will be explored through a number 
of strategies including establishing a regional bioscience platform for dialogue, advocacy and 
information exchange, and supporting BioInnovate projects with appropriate tools to help them 
overcome policy challenges associated with their projects and organizations.  
 
The project is to be implemented by Councils, Commissions and Ministries for Science and 
Technology in the region, closely working with regional STI policy organizations, among which 
are the African Technology Policy Studies Network, the International Livestock Research 
Institute, the International Service for the Acquisition of Agri-biotech Applications as well as 
international organizations in this case the Stockholm Environment Institute in Sweden. The 
activities of the project range from strategic policy studies to rending practical policy support to 
BioInnovate and other related projects in the region.  
 
In summary, the project will provide new ways of doing business for bioscience innovation in 
Eastern Africa. By supporting BioInnovate‟s project teams, the project will ultimately result in 
measurable social, economic and environmental benefits in Eastern African countries.  
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3. Background and rationale for the Project  
 
3.1 Development challenge: Realizing the potential of science, technology and innovation 
investments 
 
“It is no secret that Africa’s history has been marked by a development narrative in which the 
benefits from science, technology and innovation have been enjoyed by few, instead of being seen 
as tools for the development of all citizens. Today this is changing and Africa’s leaders view 
science, technology and innovation as critical to human development, global competitiveness 
and ecological management.”1 
 
Science, technology and innovation (STI) policies are currently at the heart of national 
development discussions in Africa. In Eastern Africa, governments are beginning to actively 
support STI development
2
 including biotechnology as tool for modernizing agriculture and 
ensuring environmental sustainability. In all Eastern Africa countries STI policies are beginning 
to take root. Some countries like Tanzania are reviewing their S&T policies, while other 
countries like Uganda are preparing strategies and plans for their implementation. This renewed 
emphasis on STI as a driver for economic growth and development reflects the African Union 
(AU) commitment to advancing S&T in continent and in some ways addresses the goals of  
AU/NEPAD Africa‟s Science and Technology Consolidated Plan of Action, 2006-2010.  
 
Expectations regarding enhanced STI investments are spurred by guarded optimism over 
Africa‟s economic prospects. With particular reference to agricultural development, Juma (2010) 
notes: “African agriculture is currently at a crossroads, at which persistent food shortages are 
compounded by threats from climate change. But […] Africa faces three major opportunities that 
can transform its agriculture into a force for economic growth: advances in science and 
technology; the creation of regional markets; and the emergence of a new crop of 
entrepreneurial leaders dedicated to the continent's economic improvement.”3 
 
Arguably, the continent, and Eastern Africa in particular, could have a competitive edge in 
developing a bio-resource based economy. Already, revolutionary advances in the field of 
biosciences are changing the conditions for the utilization of biological resources worldwide, 
including Eastern Africa. The application of modern biosciences is, for example, assisting in 
crop and animal breeding and improving efficiency in the production of disease and pest resistant 
cultivars for small scale farmers. Advances in the field of biosciences could present new agro-
processing opportunities, and lead to diversification of small-holder production. And this would 
increase demand for local crops, thereby improving rural livelihoods. Furthermore, bioscience 
innovations will help agro-process industries to be more productive and sustainable where agro-
                                                          
1
 From: Juma, C. and I. Serageldin (Lead Authors). 2007. Freedom to Innovate: Biotechnology in Africa’s 
Development. A report of the High-Level African Panel on Modern Biotechnology. Addis Ababa / Pretoria: African 
Union (AU) / New Partnership for Africa‟s Development (NEPAD). p. xv 
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Omari, D. Njubi, H. Opolot, and P. Chuwa. 2010. Fostering Bioscience Innovation: Lessons from BIO-EARN. 
Kampala, Uganda: East Africa Regional Programme and Research Network for Biotechnology, Biosafety and 
Biotechnology Policy Development. 
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waste could be converted into valuable products such as feed, bio-energy and other valuable by-
products and at the same time reduce environmental impacts. BioInnovate coupled with the 
BIPCEA project, is uniquely positioned to support the necessary institutional change for 
countries to benefit from emerging opportunities foreseen with bioscience innovations. 
 
In most of the Eastern African countries, the necessary organizations and policies seem to be in 
place. These should provide a more enabling environment for the biosciences. However, policy 
coordination between different branches of government is often lacking, e.g., in the development 
of policies and regulations regarding intellectual property protection and biosafety. The key to 
addressing this gap is in forging links among key actors at the appropriate time in the innovation 
cycle and, more particularly, in the life of the innovations in question. These links will differ 
according to the type of technological innovation (agricultural, environmental, or industrial) and 
according to whether the innovation will be disseminated through commercial (market) or, as in 
the case of “public good” technologies, through non-market channels. This Project will focus 
more on creating the necessary linkages, promoting policy coordination, and information sharing 
among key actors in the bioscience innovation system. An important element in this effort will 
be to effectively communicate for policy influence, regarding the impacts and potential of 
bioscience innovations in Eastern Africa.  
 
3.2 Making the link: the Biosciences Innovation Policy Consortium 
 
The BIPCEA project will help ensure that STI investments generally, and BioInnovate‟s efforts 
in particular result in tangible products and innovations in partner countries. This will be done by 
tackling a number of important regional policy challenges affecting bioscience innovations in the 
region, which include among others, limited access to new, affordable and eco-friendly 
technologies for crop production and agro-processing; difficulties in information exchange, 
including sharing of germplasm and its fair and equitable utilization; and few sustainable 
financing mechanisms for value addition activities and for creation of bio-based business 
enterprises. The project will approach these challenges through a participatory and action 
oriented analysis of the bioscience policy environment to facilitate evidence based decision 
making, and to provide direction for growth of a bio-economy in Eastern Africa.  
 
BIPCEA project is to be implemented by Science and Technology Councils, Commissions and 
Ministries in Eastern Africa and supported by regional S&T policy organizations and abroad 
which in this case are the African  Technology Policy Studies Network (ATPS), International 
Service for the Acquisition of Agri-biotech Applications (ISAAA), International Livestock 
Research Institute (ILRI)- Legal and Intellectual Property Office, and the Stockholm Environment 
Institute (SEI) to promote environmental sustainability issues and also to promote north south 
cooperation in STI development. The involvement of these lead S&T agencies in the region and 
abroad is expected to result in a true regional bioscience platform that will forge close linkages 
and synergies with relevant public- and private-sector R&D partners and the business community 
in each country, regional and international bioscience programs, and with donor agencies that 
share an interest in supporting bioscience innovations. 
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4. Adding value to existing efforts 
 
The Project is fully complementary with, and adds value to other ongoing efforts in bioscience 
research and policy development. The Project will actually fill an important gap in providing a 
bridging function between (i) overall bioscience and STI policy initiatives in the region (e.g., 
under AU and NEPAD); (ii) international and regional initiatives for bioscience capacity 
development (e.g., BECA hub), and (iii) existing research networks in the region (e.g., 
ASARECA).  All these initiatives are making important contributions to STI development in the 
region. However, as noted in section 3 above, further efforts are required to ensure that research 
outputs are indeed progressing to the product development and dissemination stages, and can do 
so within an enabling policy framework with the support of the S&T Councils and Commissions 
in Eastern Africa. 
 
Notably, the BIPCEA will add significant value to other BioInnovate supported projects which in 
general aim at generating value added bio-based processes and products with high commercial 
potential. This Project will provide the necessary policy support services to the BioInnovate 
projects and assist them translate research efforts into tangible innovations for the market. 
 
The BIPCEA will build on previous BIO-EARN program efforts in institutional intellectual 
property (IP) development in the network institutes, and product development partnerships in the 
region. While building on expertise developed and networks formed under the BIO-EARN 
program, this Project is different as it brings a broader and more comprehensive set of skills and 
expertise to the BioInnovate program and projects including policy analysis and policy 
advocacy. It extends to Rwanda and Burundi which were not formally part of the BIO-EARN, 
and will work closely with regional S&T policy organizations to promote biosciences 
communication and advocacy, business development and incubation as well as tackling 
regulatory bottlenecks such as in seed registration and access to germplasm and benefit sharing.  
BIPCEA is also unique in the sense that it will focus on supporting tangible innovations through 
systematic technological innovation systems analysis, and in working at the policy level to 
encourage implementation of policies and policy recommendations.  The project will also bring 
in new features in terms of a constructive and interactive bioscience policy dialogue and 
advocacy. To date, civil society - agricultural professionals, producers, marketing agents, 
consumers and even legislators - have had no forum for discussing issues affecting innovations 
development generally and bioscience innovations in particular.  BIPCEA will strive to bridge 
this gap. 
 
5. Potential for economic, environmental and social impact  
 
The role of science and technology in meeting sustainable development goals was recognized 
during the World Summit on Sustainable Development (WSSD) in 2002. The supports 
technology development, transfer and diffusion in Africa. The WSSD resolutions are reflected in 
NEPAD‟s African Bioscience Initiative and in numerous national strategies and development 
plans. Similar initiatives, such as the UN Millennium Project‟s Taskforce on Science, 
Technology and Innovation
4
 underscore the critical importance of knowledge and innovation for 
                                                          
4
 Further details and background documents can be found at URL:  
http://www.unmillenniumproject.org/reports/tf_science.htm 
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development in every country. Technological innovation and associated institutional change 
should underpin long-term growth and must be at the center of any strategy to strengthen the 
private sector.  
 
While bioscience plans and policies are increasing, what is important in current and future 
bioscience programs, such as BioInnovate, is to identify demand for a specific technology, and to 
plot and forge the essential links as early as possible in the research, development, and 
dissemination process. This policy challenge will be addressed in this Project. With increasing 
expectations from the biosciences, there are growing demands on public R&D organizations to 
create and catalyze the development of pro-poor, demand-driven innovations. However, public 
organizations in Eastern Africa are often ill-equipped to move innovation beyond the initial 
research stages and meaningfully partner with the private sector in product development and 
dissemination. This Project will provide policy support services which are necessary to move 
research ideas and products to the market, and ultimately lead to a bio-economy in Eastern 
Africa. 
 
6. Regional and international collaboration  
 
Taking a regional, Eastern Africa approach in this project is considered essential. In addition to 
the collaboration between universities, industry, end-users and government at the national level, 
collaborations across borders also have to be stimulated. This will encourage an open, problem-
focused sharing of experiences and collaboration. To ensure the successful implementation of 
STI programs and activities in different countries in Africa generally, there is need for proper 
coordination and integration of programs and activities in the innovation system into all national 
and regional development planning issues. In R&D as well, countries along common agro-
ecological zones would reap significant benefits from regional technology and information 
exchange, which offer opportunities for sharing research and development overheads, expanding 
technology markets and associated economic benefits and reducing costs. Over the years, this 
cross-border technology exchange has proven vitally important in disseminating agricultural and 
natural resource management technologies. 
 
The BioInnovate supported projects aim at generating regional public-good innovations, and this 
development will be supported by this project.  The BIPCEA will work as a fully functional 
regional mechanism, spearheaded by a team with broad bio-policy and innovation expertise, and 
actively involving institutions from the BioInnovate partner countries as well as regional and 
international S&T policy organizations in addition to the Project‟s implementing partners ATPS, 
ISAAA, ILRI Legal and Intellectual Property Office and SEI. The Consortium may also draw on 
expertise from the Economic and Social Research Foundation in Tanzania and the Pan African 
Competitiveness Forum, and any other relevant innovation policy actors in the region. All 
activities planned and implemented under BIPCEA will aim at, and incorporate cross-country, 
regional sharing of information and learning. This feature will expectedly stimulate adoption of 
innovations from BioInnovate supported science projects beyond the countries where they are 
implemented. 
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7. Project goal and objectives  
 
The overall goal of the BIPCEA, therefore, is to provide policy support services that will 
enable BioInnovate projects in Eastern Africa to successfully bring their technologies and 
business ideas to market. Achieving this goal will require, among other things, improvement in 
policies that facilitate linkages between local private actors, academia and the public sector in the 
bioscience research and innovation process. These linkages should ultimately create 
opportunities for bioscience business incubation, improve intellectual property management and 
technology licensing, increase access to genetic resources, and evolve a more sustainable 
financing mechanism for bioscience research and innovation in the region.   
 
To this end, the specific objectives of the Project are: 
 
a. To identify and evaluate policy support needs of Bio-Innovate projects in Eastern Africa. 
b. To establish a platform/forum for interaction and exchange of ideas on bioscience 
innovations and policies in Eastern Africa. 
c. To provide policy support tools for biosciences innovations and related activities in the 
region. 
 
7.1 Outputs 
 
The Project‟s key outputs expected under each of the above objectives are:  
 
Objective 1: To identify and evaluate policy support needs of BioInnovate projects in 
Eastern Africa  
 
Outputs: 
a. Four (4) case study reports on Bio-Innovate projects.  
b. A report on the review of national science, technology and innovation policies in Eastern 
Africa establishing the extent to which they promote bioscience innovations.  
c. A report on the review of the seed certification system in Eastern Africa.  
d. A protocol to facilitate seed certification in Eastern Africa. 
e. A report on the review of biosafety frameworks of the Eastern African countries.  
f. A report on access and benefit sharing regime in Eastern Africa establishing extent to 
which they support (hinder) exchange of biological materials and products.  
g. At least three (3) policy briefs emanating from the above studies. 
h. At least two (2) journal articles from the above studies. 
 
Objective 2: To establish a platform/forum for interaction and exchange of ideas on 
bioscience innovations and policies in Eastern Africa  
 
Outputs: 
a. Proceedings of a workshop on a BIPCEA and BioInnovate Projects stakeholder analysis 
and mapping showing potential strategic partners for advancing biosciences innovations 
in Eastern Africa. 
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b. Proceedings of two (2) high-level regional conferences on bioscience innovations and 
policies in Eastern Africa (one of these conferences shall involve Ministers from STI 
related sector ministries). 
c. At least eighteen (18) annual national round-tables on bioscience innovations and policy 
issues in all Bio-Innovate countries. 
d. Media coverage on key events.  
e. At least four (4) sets of bioscience policy communication materials with key messages  
f. At least fourty five (45) partnership (breakfast) meetings in all Bio-Innovate countries 
targeting key players such as Parliamentary committees on S&T, professional bodies, 
business associations, entrepreneurs and academia ). 
g. One flagship publication on bioscience innovation system and the emerging bio-economy 
in Eastern Africa. 
h. At least one (1) journal article from the above activities.  
 
Objective 3: To provide necessary policy support tools for biosciences innovations and 
related activities in the region  
 
Outputs: 
a. A training manual on entrepreneurship for BioInnovate projects. 
b. At least 150 scientists trained in entrepreneurship skills (including technology licensing 
agreements and business plan development). 
c. A report of an assessment of intellectual property assets of all Bio-Innovate partner 
organizations.  
d. A report on Freedom-to-Operate for Bio-Innovate projects. 
e. At least 80 Bio-Innovate scientists on IP. 
f. At least 100 scientists on science communication skills (including preparation of policy 
papers and message maps). 
g. Twelve (12) institutional IP policies for Bio-Innovate organizations that lack them. 
h. At least 1500 laboratory note books printed and distributed to BioInnovate partner project 
teams. 
 
7.2 Outcomes 
 
The key expected outcomes of this Project are a) that Bio-Innovate partner organizations will 
increasingly be able to develop and commercialize their bioscience innovations; and b) that 
policies, strategies and actions to promote bioscience innovations generally will be more 
prominent in the policy and development agenda in Eastern Africa. 
 
8. Methodology and description of project activities  
 
The Project will employ a participatory and action-orientated analysis and outreach, involving 
BioInnovate project partners as well as other relevant bioscience programs in region.  We will 
take an innovation systems approach in executing most of the Project‟s activities. Activities will 
be further refined through planning meetings, and implemented in a trans-disciplinary manner 
with scientific, communications, business and regulatory/policy expertise which represent the 
diverse actors in the bioscience innovation system. The Project‟s activities will be stretched to 
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cover all the six BioInnovate participating countries including Ethiopia, Burundi, Kenya, 
Rwanda, Tanzania and Uganda.   
 
8.1 Description of project activities  
 
Objective 1: To identify and analyze policy issues essential for the success of BioInnovate 
supported projects  
 
1.1 Carry out four (4) case studies of Bio-Innovate projects to identify policy gaps and needs of 
BioInnovate projects. 
 
Four (4) case studies of Bio-Innovate projects in the region will be carried out to systematically 
establish the policy gaps and needs of BioInnovate Project. The case studies will be on projects 
that represent a combination of crop and environmental bioscience innovations, and geographical 
balance of BioInnovate partner countries. Some of these projects include, for example: 
 Project 1: Delivering new sorghum and millets innovations for food security and 
improving livelihoods 
 Project 2:  Enhancing food security through improved seed systems and varieties of 
cassava, potato and sweet potato resilient to climate change 
 Project 4: Sustainable utilization of agro-industrial wastes through integration of bio-
energy and mushroom production 
 Project 5:  Integrated process for sustainable agro-process waste treatment and climate 
change mitigation 
 
We will use a Technological Innovation Systems (TIS) analytical framework for the case studies 
as most of them look to developing products and/or processes. The TIS is suitable because it 
enables analysis of the interactions among actors; and will entail a critical assessment of the 
knowledge base and diffusion, a review of relevant regional and national policies, 
entrepreneurial activities, potential markets, resource availability, acceptability of the 
innovations, and partnerships and networks which support bioscience innovation projects. Based 
on the TIS analysis, the Project team will determine strategies to address identified gaps and 
needs, and foster linkages among key actors.  
 
1.2 Review national science, technology and innovation policies in Eastern Africa to establish 
the extent to which they promote bioscience innovations  
 
While the integration of the East African Community is opening up political, economic and 
social development cooperation, the lack of policy coherence in areas such as bio-innovation are 
likely to remain a challenge to this process. It is important, therefore, that strategic science, 
technology and innovation policy studies are conducted across the region to underscore: 
 
a. Whether or not the countries have appropriate STI policies that support the development, 
uptake and commercialization of bio-innovations. 
b. The interaction between these STI policies with other relevant economic and social 
development policies e.g. economic planning, competition policies. Etc. 
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c. Areas where harmonization of STI policies should be pursued for easier integration and 
trade. 
d. The impact of these STI policies on development of bio-innovation in the region 
e. Share lessons from the experiences of the countries which are at different stages with 
their STI policies and bioscience innovation and development.  
f. Highlight areas that need urgent investment in capacity building, policy change.  
 
The essence of this policy study is to seek results that can be applied widely to solve problems of 
bio-innovation in the region, share cross-country experiences, foster networking and learning 
among the national Councils and Commissions for science and technology with other policy 
actors in the region, and provide quality advice to governments based on robust results. The 
Councils and Commissions for S&T will work hand in hand with ATPS to conduct this study. 
The study will involve engaging with relevant stakeholders (including government departments, 
policy actors, practitioners, private sector, civil society and journalists/media) in identifying and 
prioritizing specific research and policy questions to be addressed in each member country. The 
country-level analyses will be compared and contrasted to give a regional outlook on the status 
of STI policies in the region and their effect on bio-innovation. The findings of the study will be 
disseminated and shared during a planned high-level regional conference on bio-innovation in 
the third year of the project.  
 
1.3 Review the seed certification system in Eastern Africa  
 
The seed certification system in Eastern African still possesses enormous challenges to scientists 
wishing to commercialize or exchange novel or value added seed varieties in the region. 
Previous efforts by ASARECA to rationalize the regulatory and legal framework governing the 
seed industry have not borne the expected fruit and the industry remains small, fragmented and 
fraught with bottlenecks. This is evidenced by the shortage of planting seed and increasing 
imports of seed into the region to compensate for the persistent shortfalls. Since a number of 
BioInnovate projects have seed related products, policy related support in terms of harmonized 
seed certification procedures and protocols is necessary. The seed certification system in region 
will be reviewed. The review will involve interviews with actors in the seed industry as well as 
Bioinnovate project partners working on seed systems.  The review will establish status of seed 
certification in Eastern African with regard to the procedures and seed policies, and challenges 
this is posing to seed trade and germplasm exchange at the regional level. Based on this review a 
protocol to facilitate seed certification in Eastern Africa will be developed. The protocol will 
include regional certification standards, procedures for variety releases, registration, export and 
import into the BioInnovate participating countries.  
 
1.4 Review biosafety frameworks of the Eastern African countries   
 
Eastern African countries‟ national biosafety frameworks are at different levels of development 
and implementation. Though current Bio-Innovate projects are not working with genetically 
modified organisms, a functional biosafety framework in the country is essential for advancing 
bioscience innovations overall. This study will establish the status of biosafety development in 
the region and identify areas where harmonization of biosafety policies may be required. The 
review shall include the recently adopted Nagoya-Kuala Lumpur Protocol on liability and redress 
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related to biological safety. Countries in Eastern Africa are making steps to domesticate this 
agreement, which will potentially have major impact on bioscience innovations in the region.  
 
1.5 Review the access and benefit sharing regime Eastern Africa to establish extent to which they 
support (hinder) exchange of biological materials and products  
 
This will involve an intensive analysis of the state of implementation of the multilateral system 
for access and benefit sharing under the International Treaty on Plant Genetic Resources for 
Food and Agriculture (ITPGRFA) in Eastern Africa and whether its objectives are being 
achieved or not at the national and institutional level. The analysis will also include the national 
PGRFA access systems such as arrangements with private plant breeding companies and the 
further transfer of PGRFA accessed under the standard material transfer agreement (SMTA). The 
study will help explore and identify options for accessing materials such as use of bio-cultural 
protocols and other instruments to develop terms and procedures for accessing materials held by 
local communities and options for benefit sharing such as through participatory plant breeding 
and other collaborative projects; and private partnerships to access privately held material. 
Following this analysis a strategy on how best to access materials for the project partners will be 
identified.   
 
 Objective 2: To establish a platform/forum for interaction and exchange of ideas on bioscience 
innovations and policies in Eastern Africa 
 
2.1 Undertake a BIPCEA and BioInnovate Projects stakeholder analysis and map potential 
strategic partners for advancing biosciences innovations in Eastern Africa. 
 
An intensive stakeholder analysis and netmapping exercise to identify key stakeholders, and 
audiences in the BIPCEA project will be conducted. This will be done by BIPCEA team 
members through a brainstorming session during which all the stakeholders will be categorized 
according to their interest and power. „Interest‟ will be a measure of the degree they are likely to 
be affected by the project or policy change, and what degree of interest or concern they have in 
or about it. „Power‟ will be a measure of the influence they have over the project or policy, and 
to what degree they can help achieve, or block, the desired change. This analysis will also help in 
understanding groups that advocate or oppose scientific innovations taking into account the 
threats and opportunities that such groups present. Following this analysis a strategy on how best 
to engage and sustain relationships with the different stakeholders in the project will be 
identified. This will be done by bringing together all the identified strategic stakeholders in a 
workshop during which mechanisms and strategies on how to link actors in the bioscience 
innovation system will be identified and agreed on. 
 
2.2 Hold 18 annual national round-tables on bioscience innovations and policy issues in all Bio-
Innovate countries 
 
These will be country level forums involving a range of actors in the bioscience innovation 
system such as academia, policy makers, business developers and entrepreneurs and the media. 
These policy round tables will be planned for between 50 and 70 participants once every four 
months in all the six countries. They will also involve BioInnovate partners within each country, 
and may be used an opportunity to create synergies between BioInnovate projects and national 
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programmes, as well as advocacy and product development partnerships. These round tables will 
also be useful, among other things, in identifying policy issues as well as on building consensus 
on how to address those issues. These dialogues which may be one to two days will be convened 
by the national councils and commissions for science and technology in each country.  
 
2.3 Hold 45 partnership (breakfast) meetings in all Bio-Innovate countries targeting key players 
such as Parliamentary committees on S&T, professional bodies, business associations, 
entrepreneurs and academia) 
 
These will be smaller more targeted meetings aimed primarily at influencing policy change and 
building partnerships for product innovations and enterprise development. The stakeholders for 
these types of meetings will be business executives, high level policy makers, parliamentarians, 
science professions, academia, etc. These partnership meetings will be driven mainly by the 
policy needs of the BioInnovate project partners in each country. In other words, the BioInnovate 
project teams will work with the Councils and Commissions of science and technology in their 
respective countries to identify the key actors they would want for the partnership meetings. 
These meetings would involve no more than twenty participants each time. 
 
2.4 Organizing two high-level regional policy conferences on bioscience innovations in Eastern 
Africa.  
 
These will be regional conferences which will, among other things, highlight the importance of 
working regionally to develop bioscience innovations, pooling expertise and sharing resources, 
and connecting to other institutions worldwide. Each of these high level conferences is planned 
for up to one hundred (150) participants from the region and abroad. They will include all 
BioInnovate project partners, policy makers, civil society representation and other regional 
bioscience related bodies and initiatives. These conferences will be organized by the Councils 
and Commissions for S&T in consultation with the BioInnovate Program manager. One of these 
regional conferences shall specifically involve Government ministers and key decision makers 
from STI related ministries including the Ministries of Finance from each of the six countries in 
Eastern Africa as well as the East African Community. It is expected that such high level forum 
and the policy dialogues will present an opportunity for creating synergy between national 
programs and BioInnovate projects, enhance resource mobilization to support bioscience 
innovations, align BioInnovate interventions with national and regional development objectives, 
and help position biosciences among the region‟s top development priorities. 
 
2.5 Have media coverage on key events 
 
This entails maintaining a sustained engagement of the media through innovative ways and 
means. This will involve identifying key events such as the ones aforementioned, representing 
significant opportunities for strategic communication to stakeholders. Some of the media 
coverage events and engagement strategies will include news conferences, releases, press 
briefings, feature articles, opinion pieces, news advisories, calls to journalists informing them of 
key events and photo opportunities among others. 
 
2.6 Develop four (4) sets of bioscience policy communication materials with key messages 
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This will involve the development of appropriate range of robust and compelling communication 
materials to promote policy information emanating from the project. Strategic targeting and 
consistency will be key to project‟s messages.  Several tools and activities informed by the key 
audiences, messages, or a combination of the two will be used. These will include policy briefs, 
special papers, working papers and message maps.  A core message that will act as the central 
piece of information that BIPCEA aims to communicate to target audiences through every 
activity will be developed. It will provide a quick way of capturing attention and communicating 
outcomes. This will be a simple, realistic and memorable message that can be repeated severally 
to create understanding, acceptance and lead to ultimate success of the BioInnovate projects 
project efforts. 
 
2.7 Prepare a flagship publication on bioscience innovation system and the emerging bio-
economy in Eastern Africa 
 
The study reports together with the high level regional conference proceedings would result in a 
printed volume or BioInnovate flagship publication presenting case-study experiences, lessons 
learned, and prospects for and anticipated impact of current and future bioscience innovations. 
The book will deal with how bioscience innovations, and in particular the BioInnovate project 
will contribute to a more profitable, climate smart and resource efficient economy, and include 
an analysis of potential future socio economic impacts of current and planned bioscience 
innovation investments. It is expected that book would be launched in towards the end of the 
third year of BIPCEA. Efforts will be made to engage regional and international publishers to 
print and disseminate this publication to a large audience. 
 
Objective 3: To establish a forum for communication, dialogue and advocacy on bioscience 
policy issues in the region   
 
3.1 Develop a training manual on entrepreneurship  
 
This will involve the development of guidelines, processes, and procedures for conducting 
entrepreneurship training for prospective BioInnovate scientists and practitioners. It will provide 
the necessary tools for starters and the necessary requirements for successful entrepreneurship. 
 
3.2 Train 150 scientists in entrepreneurship skills (including technology licensing agreements 
and business plan development) 
 
A training workshop will be convened for BioInnovate scientists/researchers to enable them gain 
skills on the best practices in enterprise establishment, management and operations. This will 
include training on making  techno-economic feasibility studies on technology dissemination Each 
training workshop is to be attended by up to 50 participants. The training will include, among 
others, issues on enterprise due diligence, technology licensing and business plan development.  
 
3.3 Develop intellectual property management tools for all Bio-Innovate partner projects. 
 
This will involve the development and distribution to project partners of a „common IP 
operational framework‟ the purpose of which is to provide common IP management processes 
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for BioInnovate project partners. The framework will provide Guiding Principles on the 
identification, monitoring and management of their IP assets to enable the projects to capitalize 
on the potential benefits. Project partners will be provided with the resources and tools required 
for the sound management of intellectual assets in accordance with best practices to facilitate in 
making more informed decisions, such as acquiring other intellectual property assets (licensing 
in) or licensing out. 
 
3.4 Undertake a Freedom-to-Operate for Bio-Innovate projects 
 
This will be a participatory process involving the creation of IP teams within the projects to keep 
an inventory of third party IP used by the Project. An analysis of the final product will then be 
conducted to establish whether the product can be deployed without the risk of infringing 
existing third party rights.   
 
3.5 Train 80 BioInnovate scientists on IP  
 
The lack of IP awareness coupled with weak institutional mechanisms for IP management are 
constraining the development and dissemination of bioscience innovations in Eastern Africa. 
While the Bio-Earn Project, which is a predecessor to the current Bio-innovate program, 
spearheaded the development of institutional IP regimes in some of the organizations which were 
part of the program, these regimes have not been sufficiently utilized because of limited 
awareness and capacity of scientists on IP matters. Based on the planned assessment of 
intellectual assets of the bio-innovate partner organizations, as well as the freedom-to-operate a 
one week-long training for up to eighty (80) participants including researchers, policymakers, IP 
managers, research managers in the BioInnovate partner organizations will be conducted. This 
activity will draw experiences from ATPS‟ previous work on strengthening national IP policy 
and legal frameworks in East and Southern Africa.   
 
3.6 Develop in a participatory manner 12 institutional IP policies for Bio-Innovate organizations 
that lack them.  
 
This will be a participatory process that will involve identification of the organizations that do 
not have IP policies and working with the IP teams within the Projects to develop IP policies for 
these institutions. 
 
3.7 Train 100 scientists on how to reach policymakers with their research findings   
 
Training workshops for scientist involved in the BioInnovate funded projects will be held in the 
6 study countries. The objectives of the workshops will be to: i) equip the scientists with 
communications skills for effective engagement of policy makers; ii) Sharpen the skills of 
Principal Investigators (PIs) and project‟s communication personnel on media relations and 
issue-management; and equip scientists with skills to design and package comprehensive 
communication messages on the project including preparation of policy papers, special papers, 
working papers and message maps. 
 
3.8 Print and distribute 1500 laboratory note books to BioInnovate partner project teams 
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Laboratory note books will be developed, printed and provided to bio-innovate research 
teams/scientists. This activity builds on the previous BIOEARN Project which demonstrated 
increased demand and value added in utilizing the laboratory note books among participating 
organizations. The essence of having laboratory note books is to aide in patenting process should 
such possibility arise within the projects. Laboratory note books are a powerful tool to verify 
novelty claims during the patenting process. The Laboratory notebooks will be printed with a 
logo of the organization involved in the collaborative projects, and will be owned by the 
organization for which a scientist works. 
 
9. Pathway to impact  
 
Science-based innovation has been a key element in the long-term elevation of living standards 
worldwide. However, for such innovations to deliver benefits geared to economic growth, 
development and environmental sustainability, requires conducive policy environment. This 
project provides new ways of doing business for bioscience innovation in Eastern Africa. This 
way, the project will have direct impacts on public- and private-sector partners involved in 
bioscience innovation projects. Such direct impacts will be in terms of new partnerships, and 
improved organizational performance to develop and disseminate pro-poor innovations. In 
addition, the project‟s activities and outputs aimed at science communication, policy advocacy 
and outreach will be gauged in terms of, for example, increased funding allocations to 
biosciences, policy reforms that promote appropriate innovations - based on research-based 
policy recommendations - and in terms of the project‟s contributions to innovation policy 
developments and harmonized approaches in regional bodies.  
 
By actively supporting BioInnovate‟s project teams to ensure that research products progress 
through the product development and dissemination pipeline, within an enabling policy 
environment, this Project will ultimately result in measurable social, economic and 
environmental benefits in Eastern African countries. Globally, the project‟s impacts will be 
assessed in terms of its contributions to the body of literature on STI and bioscience innovation 
policy in Eastern Africa. 
 
10. Team Leadership, Composition and Roles of Partners  
 
The Project will be implemented by the national Councils, Commissions and Ministries for 
science and technology in the region. These organizations are particularly well placed to address 
bioscience and general science, technology and innovation (STI) policy questions at the country 
level, and have a strong convening role for both public and private R&D partners. They will 
work hand in hand with science and technology policy organizations in the region and abroad 
which in this case are ATPS, ISAAA, ILRI, and SEI. The regional STI policy organizations will 
provide any necessary expertise for the Councils, Commissions and Ministries for S&T to 
successfully carry out activities of this Project. Such expertise which has been identified in this 
Project includes, but is not limited to, STI policy analysis, entrepreneurship skills development, 
intellectual property management and science communication.    
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11. Competence and skill track record of Principal Investigator 
 
The team leader / PI is Mr. Julius Ecuru
5
, at present the Assistant Executive Secretary of the 
Uganda National Council for Science and Technology.  At UNCST, he is responsible for 
research and development policy management and oversight, management of science and 
innovation projects, ensuring human and environmental safety in the conduct of research, and 
institutional development planning. His division has 12 core technical and professional staff.   
Mr. Ecuru brings over 12 years of experience in STI policy development and implementation. He 
is well connected to several regional initiatives in STI, and participated as co-PI in the BIO-
EARN policy project, leading the development of several STI policy studies, policy briefs and 
outreach events. Mr. Ecuru brings broad project management experience and communication 
skills to the team, which is essential in leading a multi-country, multi-disciplinary team.  His 
recent track record includes the following research grant management experiences: 
 
(1) Project Implementation Coordinator, Uganda Millennium Science Initiative (MSI, 2006-
2011): Uganda MSI is a 5-year US$ 33.35 million, being implemented by UNCST. It is co-
financed by the World Bank (US$ 30 million) and Government of Uganda (US$ 3.35 million). 
MSI has two components: 1) grants facility and 2) institutional strengthening. Component 1 
currently has 39 research and curriculum development projects running, while component 2 
refurbished pilot plants and set up a business incubation service and a technology development 
centre at the Uganda Industrial Research Institute. The second component also involved 
strengthening UNCST and science outreach, policy studies and monitoring and evaluation. The 
project has a core team of 10 members.  
 
(2) Co-PI, Enhancing product development opportunities and supportive policies (2006-2010): 
This was part of an East African regional project under BIO-EARN aimed at bioscience policy 
analysis and institutional policy development. Budget for the Uganda component totaled around 
US$ 180,000. The project initiated processes for establishing policies that promote product 
development and commercialization of innovations, including management of intellectual 
property in selected organizations and strategic partnerships for uptake of innovations. The 
project team involved 7 members in Uganda. 
 
(3) Project Manager (Technical), Strengthening the scientific and ethical review system in 
Uganda Project (2008-2010). This was a Euro 50,000 European and Developing Countries 
Clinical Trials Partnership (EDCTP) grant aimed at setting up accreditation system for research 
ethics committees, and establishing networking forums for bioethics in Uganda. The project had 
a core team of 5 members. 
 
The PI‟s host institute, UNCST, has a strong track record in adequately managing and 
accounting for externally funded projects. These include, apart from the projects mentioned 
above, the following: 
                                                          
5
 Suggested referees:  (i) Dr. Maxwell Otim, deputy Executive Secretary, Uganda National Commission for Science 
and Technology (UNCST); e-mail: info@uncst.go.ug; (ii) Prof. Panta Kasoma, Executive Director, Jane Goodall 
Institute, Uganda; e-mail: info@jgiuganda.org 
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 ACACIA Project for Information and Communication Technology for Rural 
Development, funded by IDRC (Canada) 
 UNEP-GEF Project on the Implementation of a National Biosafety Framework, funded 
by the Global Environment Facility (GEF) 
 Bioethics Capacity Building, funded by the National Institutes of Health (NIH) and Johns 
Hopkins University 
 Project on Bioremediation, funded by the European Union 
 
12. Matching funds  
 
This Project benefits from strong buy-in by the Councils and Commissions for S&T in the region 
as well as the collaborating organizations. Matching support will include, but will not be limited 
to the following: 
 Staff time: The project team members will be financially supported by their own 
organizations to ensure proper implementation of collaborative activities, as well as 
providing support staff involved in organizing policy analysis activities and outreach 
events; 
 Supporting meetings and events: Further in-kind contributions are provided by 
participating organizations hosting planning and coordination meetings, outreach and 
training events, providing facilities and logistical support at no charges; 
 
13. Institutional support  
 
Support letters from partner organizations are submitted to BioInnovate separately, confirming 
staff availability and matching contributions to ensure proper implementation of project 
activities. The Project builds on structures and practices developed under the BIO-EARN‟s 
policy project, which benefited from strong institutional support by S&T commissions / councils 
in partner countries Ethiopia, Kenya, Tanzania and Uganda and now extending to Burundi also. 
Buy-in from national government agencies will ensure continuity from previous activities and 
project impact, beyond the life of this 3-year project. 
 
14. Monitoring and Evaluation, dissemination and communication plan 
 
Considerable attention will be paid to tracking the Project‟s performance and analyzing its 
impact, in consultation with the BioInnovate team and Technical Advisory Committee (TAC). 
The following main mechanisms and specific steps will be used to implement rigorous 
monitoring and evaluation, and to establish a performance-based team culture: 
 
(1)  Regular performance-based planning, monitoring and evaluation will be a critical feature, 
supported by the Project‟s overall logframe and GANTT charts. Annual work plans for the 
Project, and for specific activities, will include a performance plan organized around the key 
expected outputs and outcomes, associated performance indicators and show how planned 
activities contribute to achieving the project‟s objectives. The implementing partners are 
primarily responsible for timely execution of activities. Regular team interactions (face-to-face 
meetings, in-country visits, e-mail exchange / listserver and via telephone Skype conference 
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calls) and action points will serve as the main monitoring tool for the management team, in 
addition to regular reporting and progress and performance. 
 
(2)  Work plan development will be informed by seeking critical inputs from a wide range of 
project partners and public / private stakeholders. Planning meetings will be held either prior to 
completion of annual work plans, or as a mid-term review meeting, with a view to ensuring 
strategic direction, coordination and coherence across countries and thematic areas.  Project 
progress reports will be submitted every 6 months to BioInnovate management. Such reports will 
be focused on actual achievements and performance indicators, while an annual impact report 
will be submitted with more detailed descriptions of completed activities and milestones 
achieved.  
 
(3) Outreach activities will be systematically evaluated by standardized participant surveys and 
action plans that monitor the results of outreach and training events after they have taken place. 
Any printed publications will undergo external peer review prior to printing and distribution. 
 
(4)  It is proposed that an external evaluation will be commissioned early on in the 3
rd
 year of 
project, possibly as part of an overall BioInnovate external evaluation, to provide an independent 
assessment of actual results against performance targets, and analyzing overall impact from 
BioInnovate‟s support. 
 
These mechanisms will ensure the overall Project quality and resulting outputs, and the Project‟s 
relevance in relation to expected outcomes. 
 
14.1  Communication and dissemination plan 
 
Outreach and communication activities, primarily aimed at policymakers in national and regional 
organizations, are an integral part of this Project as shown in the summary of the Project‟s 
objectives, methodology and planned activities. In collaboration with project partners, in 
particular the ISAAA-AfriCenter and ATPS a detailed communication strategy will be 
developed and adopted early-on in the Project. Generally, all outputs and recommendations 
emerging from this Project will be reviewed and disseminated through policy dialogues, 
consultations and seminars at country- and regional level, in order to ensure that policy 
recommendations and management guidance are actually taken up by government agencies, and 
public- and private-sector institutions.  
 
15. Intellectual Property and other policy issues  
 
The intellectual property envisaged to arise from this Project relate mainly to copyright. The 
Project team will acknowledge every source of material that will be accessed and used in the 
studies. Significant contributions from individuals and organizations made to this Project will 
also be acknowledged. Policy briefs, reports, journal articles, proceedings and similar works will 
be co-authored by the Project team and implementing partners, except for very specific national 
activities where the other partners are not actively involved. Activities at national and regional 
level will acknowledge “BIPCEA” and all the implementing and collaborating partners, 
including where appropriate logos of the organizations involved. Due credit and recognition shall 
be given to Sida and the BioInnovate programme for their support of the Project. Since this 
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Project does not aim at collecting personal identifiable information, we do not envisage any 
serious ethical issues. However, where key informant interviews will be necessary informed 
consent of the respondents will be obtained appropriately prior to the interviews. In addition, 
where necessary the Project team shall maintain confidentiality of information deemed to be 
confidential by the persons or organizations providing it. Lastly, the Project does not pose any 
environmental or social risks.    
 
16. Milestones and time frame 
 
This is a 3-year project with a tentative timeframe from August 1, 2011 – July 31, 2014. Detailed 
GANTT charts showing major activities by objectives and associated milestones will be included 
as part of the project‟s annual work plans. The Project activity plans (section 18 below) and 
logical framework matrix (Annex 1) provide details regarding the Project‟s major milestones and 
timeframe.  
 
17. Indicators of progress towards results  
 
Performance indicators for the Project and cumulative targets for the period August 2011- July 
2014 are included in the logframe below. More detailed, annual targets will be defined as part of 
annual work plans for each country and across countries for regional activities and events.  
 
18. Project activity plan 
 
Table 1 below shows the major activities plan and the implementing partners.  
 
Table1: Project activity plan 
 Activity Year 1 Year 2 Year 3 Implementing 
partners 
  1 H 2H 1H 2H 1H 2H  
1.1 Project inception meeting       UNCST 
1.2 Case studies of Bio-Innovate projects.        UNCST+NCSTs 
1.3 Review national STI policies in Eastern Africa.        ATPS +NCSTs 
1.4 Review seed certification system in Eastern Africa.        KNCST+NCSTs 
1.5 Develop a protocol to facilitate seed certification.       KNCST+NCSTs 
1.6 Review biosafety frameworks of Eastern Africa.         COSTECH + SEI 
1.7 Review access and benefit sharing regime in Eastern 
Africa.  
      MoST/AAU + 
ILRI + NCSTs  
2.1 Workshop on BIPCEA and BioInnovate Projects 
stakeholder analysis and mapping  
      UNCST + ISAAA 
2.2 Annual national round-tables on bioscience 
innovations and policy issues in all Bio-Innovate 
countries. 
      NCSTs 
2.3 Partnership (breakfast) meetings in all Bio-Innovate 
countries. 
      NCSTs 
2.4 High-level regional conference on bioscience 
innovations and policies in Eastern Africa. 
      UNCST + DSTR 
2.5 Media coverage on key events.        ISAAA 
2.6 Preparation of bioscience policy communication 
materials with key messages  
      ISAAA 
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2.7 Preparing a flagship publication on bioscience 
innovation system and the emerging bio-economy in 
Eastern Africa. 
      UNCST+SEI 
3.1 Preparing training manual on entrepreneurship for 
BioInnovate projects. 
      ATPS 
3.2 Entrepreneurship skills training for scientists.       ATPS 
3.3 Preparing IP management tools for all Bio-Innovate 
partner organizations.  
      ILRI 
3.4 Freedom-to-Operate assessment for Bio-Innovate 
projects. 
      ILRI 
3.5 IP training for BioInnovate scientists.       ATPS 
3.6 Developing institutional IP policies for Bio-Innovate 
organizations that lack them. 
      ILRI + NCSTs  
3.7 Science communication skills training for 
BioInnovate Scientists. 
      ISAAA 
3.8 Printing & disseminating lab note books BioInnovate 
project teams. 
      COSTECH 
3.9 Writing policy briefs, papers & manuscripts       ALL 
Note: Milestones are indicated by the shaded regions in the table. 
 
19. Summary project budget (US$)  
 
The total requested grant amounts to US$ 980,175 (Nine hundred and eighty thousand one 
hundred and seventy five only). The detailed budget is provided as a separate excel file annexed 
to this proposal. However, below is a summary annual budget for each of the implementing 
partners.  
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Table 2: Summary annual budget for each implementing partner 
 
APPROVED PROJECT SUMMARY BUDGET 
 
Budget Title: Biosciences Innovation Policy Consortium for Eastern Africa (BIPCEA) 
Lead Implementing Institution: Uganda National Council for Science and Technology (UNCST) 
Partner Implementing Institutions: ILRI, ISAAA, KNCST, MoST-AAU, SEI, DST-Rwanda, ATPS, COSTECH, 
Period: 3 year, 2011-2014 
Year 1 
Activity Budget Categories UNCST MoST/AAU KNCST DST-MoE-R COSTECH ATPS ISAAA ILRI SEI Total 
A Equipment and Consumables         1,500             1,500         1,500               1,500            1,500           -             -             -             -          7,500  
B Travel         3,000             3,000         3,000               4,000            3,000       3,000       3,000       3,000       6,000      31,000  
C Field work, training and dissemination       38,700           25,650       26,650             26,400          48,700     31,900     36,700     26,700       5,450    266,850  
D General project expenses         7,550             1,800         2,600               1,450            1,850       2,100       2,100       2,100       2,550      24,100  
E Overheads          2,538             1,598         1,688               1,668            2,753       1,850       2,090       1,590         700      16,473  
  Total Year 1      53,288         33,548      35,438           35,018        57,803    38,850    43,890    33,390    14,700    345,923  
                        
Year 2 
Activity Budget Categories UNCST MoST/AAU KNCST DST-MoE-R COSTECH ATPS ISAAA ILRI SEI Total 
A Equipment and Consumables             -                   -               -                     -                  -             -             -             -             -               -    
B Travel         3,000             3,000         3,000               4,000            3,000       3,000       3,000       3,000       6,000      31,000  
C Field work, training and dissemination       91,400           26,650       27,150             26,200          28,600     28,900     32,600     24,100     10,950    296,550  
D General project expenses         6,600             1,600           900               1,100            1,850       1,100       1,200       1,100       2,200      17,650  
E Overheads          5,050             1,563         1,553               1,565            1,673       1,500       1,840       1,410         958      17,260  
  Total Year 2    106,050         32,813      32,603           32,865        35,123    34,650    38,640    29,610    20,108    359,310  
                        
Year 3 
Activity Budget Categories UNCST MoST/AAU KNCST DST-MoE-R COSTECH ATPS ISAAA ILRI SEI Total 
A Equipment and Consumables             -                   -               -                     -                  -             -             -             -             -               -    
B Travel         3,000             3,000         3,000               3,000            3,000       3,000       3,000       3,000       6,000      30,000  
C Field work, training and dissemination       22,500           21,300       21,800             94,500          20,300       2,300     11,300       6,800     14,500    215,300  
D General project expenses         6,300               850         1,050               1,200              850         750         650         850       1,050      13,550  
E Overheads          1,590             1,258         1,293               4,935            1,208         303         748         533       1,078      12,943  
  Total Year 3      33,390         26,408      27,143         103,635        25,358      6,353    15,698    11,183    22,628    271,793  
                        
  Total Year 1 - Year 3    192,728         92,768      95,183         171,518      118,283    79,853    98,228    74,183    57,435    980,175  
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Appendix A: Work plan and Budget 
 
Project Title: Biosciences Innovation Policy Consortium for Eastern Africa (BIPCEA)  
  
Partner Institution: Uganda National Council for Science and Technology 
 
Description of project Activities  
 
Objective 1: To identify and analyze policy issues essential for the success of BioInnovate supported 
projects  
 
1.1 Carry out four (4) case studies of Bio-Innovate projects to identify policy gaps and needs of 
BioInnovate projects. 
 
Four (4) case studies of Bio-Innovate projects in the region will be carried out to systematically establish 
the policy gaps and needs of BioInnovate Project. The case studies will be on projects that represent a 
combination of crop and environmental bioscience innovations, and geographical balance of BioInnovate 
partner countries. Some of these projects include, for example: 
 Project 1: Delivering new sorghum and millets innovations for food security and improving 
livelihoods 
 Project 2:  Enhancing food security through improved seed systems and varieties of cassava, 
potato and sweet potato resilient to climate change 
 Project 4: Sustainable utilization of agro-industrial wastes through integration of bio-energy and 
mushroom production 
 Project 5:  Integrated process for sustainable agro-process waste treatment and climate change 
mitigation 
 
We will use a Technological Innovation Systems (TIS) analytical framework for the case studies as most 
of them look to developing products and/or processes. The TIS is suitable because it enables analysis of 
the interactions among actors; and will entail a critical assessment of the knowledge base and diffusion, a 
review of relevant regional and national policies, entrepreneurial activities, potential markets, resource 
availability, acceptability of the innovations, and partnerships and networks which support bioscience 
innovation projects. Based on the TIS analysis, the Project team will determine strategies to address 
identified gaps and needs, and foster linkages among key actors.  
 
1.2 Review national science, technology and innovation policies in Eastern Africa to establish the extent 
to which they promote bioscience innovations  
 
While the integration of the East African Community is opening up political, economic and social 
development cooperation, the lack of policy coherence in areas such as bio-innovation are likely to 
remain a challenge to this process. It is important, therefore, that strategic science, technology and 
innovation policy studies are conducted across the region to underscore: 
 
g. Whether or not the countries have appropriate STI policies that support the development, uptake 
and commercialization of bio-innovations. 
h. The interaction between these STI policies with other relevant economic and social development 
policies e.g. economic planning, competition policies. Etc. 
i. Areas where harmonization of STI policies should be pursued for easier integration and trade. 
j. The impact of these STI policies on development of bio-innovation in the region 
k. Share lessons from the experiences of the countries which are at different stages with their STI 
policies and bioscience innovation and development.  
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l. Highlight areas that need urgent investment in capacity building, policy change.  
 
The essence of this policy study is to seek results that can be applied widely to solve problems of bio-
innovation in the region, share cross-country experiences, foster networking and learning among the 
national Councils and Commissions for science and technology with other policy actors in the region, and 
provide quality advice to governments based on robust results. The study will be done hand in hand with 
ATPS. The study will involve engaging with relevant stakeholders (including government departments, 
policy actors, practitioners, private sector, civil society and journalists/media) in identifying and 
prioritizing specific research and policy questions to be addressed in each member country. The country-
level analyses will be compared and contrasted to give a regional outlook on the status of STI policies in 
the region and their effect on bio-innovation. The findings of the study will be disseminated and shared 
during a planned high-level regional conference on bio-innovation in the third year of the project.  
 
1.3 Review the seed certification system in Eastern Africa  
 
The seed certification system in Eastern African still possesses enormous challenges to scientists wishing 
to commercialize or exchange novel or value added seed varieties in the region. Previous efforts by 
ASARECA to rationalize the regulatory and legal framework governing the seed industry have not borne 
the expected fruit and the industry remains small, fragmented and fraught with bottlenecks. This is 
evidenced by the shortage of planting seed and increasing imports of seed into the region to compensate 
for the persistent shortfalls. Since a number of BioInnovate projects have seed related products, policy 
related support in terms of harmonized seed certification procedures and protocols is necessary. The seed 
certification system in region will be reviewed. The review will involve interviews with actors in the seed 
industry as well as Bioinnovate project partners working on seed systems.  The review will establish 
status of seed certification in Eastern African with regard to the procedures and seed policies, and 
challenges this is posing to seed trade and germplasm exchange at the regional level. Based on this review 
a protocol to facilitate seed certification in Eastern Africa will be developed. The protocol will include 
regional certification standards, procedures for variety releases, registration, export and import into the 
BioInnovate participating countries.  
 
1.4 Review biosafety frameworks of the Eastern African countries   
 
Eastern African countries‟ national biosafety frameworks are at different levels of development and 
implementation. Though current Bio-Innovate projects are not working with genetically modified 
organisms, a functional biosafety framework in the country is essential for advancing bioscience 
innovations overall. This study will establish the status of biosafety development in the region and 
identify areas where harmonization of biosafety policies may be required. The review shall include the 
recently adopted Nagoya-Kuala Lumpur Protocol on liability and redress related to biological safety. 
Countries in Eastern Africa are making steps to domesticate this agreement, which will potentially have 
major impact on bioscience innovations in the region.  
 
1.5 Review the access and benefit sharing regime Eastern Africa to establish extent to which they support 
(hinder) exchange of biological materials and products  
 
This will involve an intensive analysis of the state of implementation of the multilateral system for access 
and benefit sharing under the International Treaty on Plant Genetic Resources for Food and Agriculture 
(ITPGRFA) in Eastern Africa and whether its objectives are being achieved or not at the national and 
institutional level. The analysis will also include the national PGRFA access systems such as 
arrangements with private plant breeding companies and the further transfer of PGRFA accessed under 
the standard material transfer agreement (SMTA). The study will help explore and identify options for 
accessing materials such as use of bio-cultural protocols and other instruments to develop terms and 
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procedures for accessing materials held by local communities and options for benefit sharing such as 
through participatory plant breeding and other collaborative projects; and private partnerships to access 
privately held material. Following this analysis a strategy on how best to access materials for the project 
partners will be identified.   
 
 Objective 2: To establish a platform/forum for interaction and exchange of ideas on bioscience 
innovations and policies in Eastern Africa 
 
2.1 Undertake a BIPCEA and BioInnovate Projects stakeholder analysis and map potential strategic 
partners for advancing biosciences innovations in Eastern Africa. 
 
An intensive stakeholder analysis and netmapping exercise to identify key stakeholders, and audiences in 
the BIPCEA project will be conducted. This will be done by BIPCEA team members through a 
brainstorming session during which all the stakeholders will be categorized according to their interest and 
power. „Interest‟ will be a measure of the degree they are likely to be affected by the project or policy 
change, and what degree of interest or concern they have in or about it. „Power‟ will be a measure of the 
influence they have over the project or policy, and to what degree they can help achieve, or block, the 
desired change. This analysis will also help in understanding groups that advocate or oppose scientific 
innovations taking into account the threats and opportunities that such groups present. Following this 
analysis a strategy on how best to engage and sustain relationships with the different stakeholders in the 
project will be identified. This will be done by bringing together all the identified strategic stakeholders in 
a workshop during which mechanisms and strategies on how to link actors in the bioscience innovation 
system will be identified and agreed on. 
 
2.2 Hold 3 annual national round-tables on bioscience innovations and policy issues in all Bio-Innovate 
countries 
 
These will be country level forums involving a range of actors in the bioscience innovation system such 
as academia, policy makers, business developers and entrepreneurs and the media. These policy round 
tables will be planned for between 50 and 70 participants once every four months in all the six countries. 
They will also involve BioInnovate partners within each country, and may be used an opportunity to 
create synergies between BioInnovate projects and national programmes, as well as advocacy and product 
development partnerships. These round tables will also be useful, among other things, in identifying 
policy issues as well as on building consensus on how to address those issues. These dialogues which 
may be one to two days will be convened by the national councils and commissions for science and 
technology in each country.  
 
2.3 Hold 9 partnership (breakfast) meetings in all Bio-Innovate countries targeting key players such as 
Parliamentary committees on S&T, professional bodies, business associations, entrepreneurs and 
academia) 
 
These will be smaller more targeted meetings aimed primarily at influencing policy change and building 
partnerships for product innovations and enterprise development. The stakeholders for these types of 
meetings will be business executives, high level policy makers, parliamentarians, science professions, 
academia, etc. These partnership meetings will be driven mainly by the policy needs of the BioInnovate 
project partners in each country. In other words, the BioInnovate project teams will work with the 
Councils and Commissions of science and technology in their respective countries to identify the key 
actors they would want for the partnership meetings. These meetings would involve no more than twenty 
participants each time. 
 
2.4 Organizing one high-level regional policy conferences on bioscience innovations in Eastern Africa.  
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These will be a regional conference which will, among other things, highlight the importance of working 
regionally to develop bioscience innovations, pooling expertise and sharing resources, and connecting to 
other institutions worldwide. The high level conference is planned for up to one hundred (150) 
participants from the region and abroad. It will include all BioInnovate project partners, policy makers, 
civil society representation and other regional bioscience related bodies and initiatives. The conference 
will be organized by the UNCST consultation with the BioInnovate Program manager. The conference 
shall specifically involve key decision makers from STI related ministries including the Ministries of 
Finance from each of the six countries in Eastern Africa as well as the East African Community. It is 
expected that such high level forum and the policy dialogue will present an opportunity for creating 
synergy between national programs and BioInnovate projects, enhance resource mobilization to support 
bioscience innovations, align BioInnovate interventions with national and regional development 
objectives, and help position biosciences among the region‟s top development priorities. 
 
2.7 Prepare a flagship publication on bioscience innovation system and the emerging bio-economy in 
Eastern Africa 
 
The study reports together with the high level regional conference proceedings would result in a printed 
volume or BioInnovate flagship publication presenting case-study experiences, lessons learned, and 
prospects for and anticipated impact of current and future bioscience innovations. The book will deal with 
how bioscience innovations, and in particular the BioInnovate project will contribute to a more profitable, 
climate smart and resource efficient economy, and include an analysis of potential future socio economic 
impacts of current and planned bioscience innovation investments. It is expected that book would be 
launched in towards the end of the third year of BIPCEA. Efforts will be made to engage regional and 
international publishers to print and disseminate this publication to a large audience. 
 
Objective 3: To establish a forum for communication, dialogue and advocacy on bioscience policy issues 
in the region   
 
3.6 Develop in a participatory manner 12 institutional IP policies for Bio-Innovate organizations that 
lack them.  
 
This will be a participatory process that will involve identification of the organizations that do not have IP 
policies and working with the IP teams within the Projects to develop IP policies for these institutions. 
 
3.7 Project Inception Meeting 
 
Organize BIPCEA project inception meeting. About 40 participants from the region including the 
BIPCEA project team are expected to attend the Project inception meeting. BioInnovate TAC and 
Secretariat will be invited as well as representatives from BioInnovate supported projects. The purpose of 
the meeting is to engage with BIPCEA stakeholders early on in the project and understand their 
expectations of BIPCEA, to bring all Project partners to the same page and clarify to them 
implementation issues, and garner support for BIPCEA from leadership of the implementing partner‟s 
organizations. The inception meeting will take place in Kampala and will be hosted by the UNCST.  
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Project Title: Biosciences Innovation Policy Consortium for Eastern Africa (BIPCEA)  
  
Partner Institution: Ministry of Science and Technology/Addis Ababa University 
 
Description of project Activities  
 
Objective 1: To identify and analyze policy issues essential for the success of BioInnovate supported 
projects  
 
1.1 Carry out four (4) case studies of Bio-Innovate projects to identify policy gaps and needs of 
BioInnovate projects. 
 
Four (4) case studies of Bio-Innovate projects in the region will be carried out to systematically establish 
the policy gaps and needs of BioInnovate Project. The case studies will be on projects that represent a 
combination of crop and environmental bioscience innovations, and geographical balance of BioInnovate 
partner countries. Some of these projects include, for example: 
 Project 1: Delivering new sorghum and millets innovations for food security and improving 
livelihoods 
 Project 2:  Enhancing food security through improved seed systems and varieties of cassava, 
potato and sweet potato resilient to climate change 
 Project 4: Sustainable utilization of agro-industrial wastes through integration of bio-energy and 
mushroom production 
 Project 5:  Integrated process for sustainable agro-process waste treatment and climate change 
mitigation 
 
We will use a Technological Innovation Systems (TIS) analytical framework for the case studies as most 
of them look to developing products and/or processes. The TIS is suitable because it enables analysis of 
the interactions among actors; and will entail a critical assessment of the knowledge base and diffusion, a 
review of relevant regional and national policies, entrepreneurial activities, potential markets, resource 
availability, acceptability of the innovations, and partnerships and networks which support bioscience 
innovation projects. Based on the TIS analysis, the Project team will determine strategies to address 
identified gaps and needs, and foster linkages among key actors.  
 
1.2 Review national science, technology and innovation policies in Eastern Africa to establish the extent 
to which they promote bioscience innovations  
 
While the integration of the East African Community is opening up political, economic and social 
development cooperation, the lack of policy coherence in areas such as bio-innovation are likely to 
remain a challenge to this process. It is important, therefore, that strategic science, technology and 
innovation policy studies are conducted across the region to underscore: 
 
a. Whether or not the countries have appropriate STI policies that support the development, uptake 
and commercialization of bio-innovations. 
b. The interaction between these STI policies with other relevant economic and social development 
policies e.g. economic planning, competition policies. Etc. 
c. Areas where harmonization of STI policies should be pursued for easier integration and trade. 
d. The impact of these STI policies on development of bio-innovation in the region 
e. Share lessons from the experiences of the countries which are at different stages with their STI 
policies and bioscience innovation and development.  
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f. Highlight areas that need urgent investment in capacity building, policy change.  
 
The essence of this policy study is to seek results that can be applied widely to solve problems of bio-
innovation in the region, share cross-country experiences, foster networking and learning among the 
national Councils and Commissions for science and technology with other policy actors in the region, and 
provide quality advice to governments based on robust results. The study will be conducted hand in hand 
with ATPS. The study will involve engaging with relevant stakeholders (including government 
departments, policy actors, practitioners, private sector, civil society and journalists/media) in identifying 
and prioritizing specific research and policy questions to be addressed in each member country. The 
country-level analyses will be compared and contrasted to give a regional outlook on the status of STI 
policies in the region and their effect on bio-innovation. The findings of the study will be disseminated 
and shared during a planned high-level regional conference on bio-innovation in the third year of the 
project.  
 
1.3 Review the seed certification system in Eastern Africa  
 
The seed certification system in Eastern African still possesses enormous challenges to scientists wishing 
to commercialize or exchange novel or value added seed varieties in the region. Previous efforts by 
ASARECA to rationalize the regulatory and legal framework governing the seed industry have not borne 
the expected fruit and the industry remains small, fragmented and fraught with bottlenecks. This is 
evidenced by the shortage of planting seed and increasing imports of seed into the region to compensate 
for the persistent shortfalls. Since a number of BioInnovate projects have seed related products, policy 
related support in terms of harmonized seed certification procedures and protocols is necessary. The seed 
certification system in region will be reviewed. The review will involve interviews with actors in the seed 
industry as well as Bioinnovate project partners working on seed systems.  The review will establish 
status of seed certification in Eastern African with regard to the procedures and seed policies, and 
challenges this is posing to seed trade and germplasm exchange at the regional level. Based on this review 
a protocol to facilitate seed certification in Eastern Africa will be developed. The protocol will include 
regional certification standards, procedures for variety releases, registration, export and import into the 
BioInnovate participating countries.  
 
1.4 Review biosafety frameworks of the Eastern African countries   
 
Eastern African countries‟ national biosafety frameworks are at different levels of development and 
implementation. Though current Bio-Innovate projects are not working with genetically modified 
organisms, a functional biosafety framework in the country is essential for advancing bioscience 
innovations overall. This study will establish the status of biosafety development in the region and 
identify areas where harmonization of biosafety policies may be required. The review shall include the 
recently adopted Nagoya-Kuala Lumpur Protocol on liability and redress related to biological safety. 
Countries in Eastern Africa are making steps to domesticate this agreement, which will potentially have 
major impact on bioscience innovations in the region.  
 
1.5 Review the access and benefit sharing regime Eastern Africa to establish extent to which they support 
(hinder) exchange of biological materials and products  
 
This will involve an intensive analysis of the state of implementation of the multilateral system for access 
and benefit sharing under the International Treaty on Plant Genetic Resources for Food and Agriculture 
(ITPGRFA) in Eastern Africa and whether its objectives are being achieved or not at the national and 
institutional level. The analysis will also include the national PGRFA access systems such as 
arrangements with private plant breeding companies and the further transfer of PGRFA accessed under 
the standard material transfer agreement (SMTA). The study will help explore and identify options for 
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accessing materials such as use of bio-cultural protocols and other instruments to develop terms and 
procedures for accessing materials held by local communities and options for benefit sharing such as 
through participatory plant breeding and other collaborative projects; and private partnerships to access 
privately held material. Following this analysis a strategy on how best to access materials for the project 
partners will be identified.   
 
 Objective 2: To establish a platform/forum for interaction and exchange of ideas on bioscience 
innovations and policies in Eastern Africa 
 
2.2 Hold 3 annual national round-tables on bioscience innovations and policy issues in all Bio-Innovate 
countries 
 
These will be country level forums involving a range of actors in the bioscience innovation system such 
as academia, policy makers, business developers and entrepreneurs and the media. These policy round 
tables will be planned for between 50 and 70 participants once every four months in all the six countries. 
They will also involve BioInnovate partners within each country, and may be used an opportunity to 
create synergies between BioInnovate projects and national programmes, as well as advocacy and product 
development partnerships. These round tables will also be useful, among other things, in identifying 
policy issues as well as on building consensus on how to address those issues. These dialogues which 
may be one to two days will be convened by the national councils and commissions for science and 
technology in each country.  
 
2.3 Hold 9 partnership (breakfast) meetings in all Bio-Innovate countries targeting key players such as 
Parliamentary committees on S&T, professional bodies, business associations, entrepreneurs and 
academia) 
 
These will be smaller more targeted meetings aimed primarily at influencing policy change and building 
partnerships for product innovations and enterprise development. The stakeholders for these types of 
meetings will be business executives, high level policy makers, parliamentarians, science professions, 
academia, etc. These partnership meetings will be driven mainly by the policy needs of the BioInnovate 
project partners in each country. In other words, the BioInnovate project teams will work with the 
Councils and Commissions of science and technology in their respective countries to identify the key 
actors they would want for the partnership meetings. These meetings would involve no more than twenty 
participants each time. 
 
Objective 3: To establish a forum for communication, dialogue and advocacy on bioscience policy issues 
in the region   
 
3.6 Develop in a participatory manner 12 institutional IP policies for Bio-Innovate organizations that 
lack them.  
 
This will be a participatory process that will involve identification of the organizations that do not have IP 
policies and working with the IP teams within the Projects to develop IP policies for these institutions. 
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Project Title: Biosciences Innovation Policy Consortium for Eastern Africa (BIPCEA)  
  
Partner Institution: National Council for Science and Technology, Kenya (KNCST) 
 
Description of project Activities  
 
Objective 1: To identify and analyze policy issues essential for the success of BioInnovate supported 
projects  
 
1.1 Carry out four (4) case studies of Bio-Innovate projects to identify policy gaps and needs of 
BioInnovate projects. 
 
Four (4) case studies of Bio-Innovate projects in the region will be carried out to systematically establish 
the policy gaps and needs of BioInnovate Project. The case studies will be on projects that represent a 
combination of crop and environmental bioscience innovations, and geographical balance of BioInnovate 
partner countries. Some of these projects include, for example: 
 Project 1: Delivering new sorghum and millets innovations for food security and improving 
livelihoods 
 Project 2:  Enhancing food security through improved seed systems and varieties of cassava, 
potato and sweet potato resilient to climate change 
 Project 4: Sustainable utilization of agro-industrial wastes through integration of bio-energy and 
mushroom production 
 Project 5:  Integrated process for sustainable agro-process waste treatment and climate change 
mitigation 
 
We will use a Technological Innovation Systems (TIS) analytical framework for the case studies as most 
of them look to developing products and/or processes. The TIS is suitable because it enables analysis of 
the interactions among actors; and will entail a critical assessment of the knowledge base and diffusion, a 
review of relevant regional and national policies, entrepreneurial activities, potential markets, resource 
availability, acceptability of the innovations, and partnerships and networks which support bioscience 
innovation projects. Based on the TIS analysis, the Project team will determine strategies to address 
identified gaps and needs, and foster linkages among key actors.  
 
1.2 Review national science, technology and innovation policies in Eastern Africa to establish the extent 
to which they promote bioscience innovations  
 
While the integration of the East African Community is opening up political, economic and social 
development cooperation, the lack of policy coherence in areas such as bio-innovation are likely to 
remain a challenge to this process. It is important, therefore, that strategic science, technology and 
innovation policy studies are conducted across the region to underscore: 
 
a. Whether or not the countries have appropriate STI policies that support the development, uptake 
and commercialization of bio-innovations. 
b. The interaction between these STI policies with other relevant economic and social development 
policies e.g. economic planning, competition policies. Etc. 
c. Areas where harmonization of STI policies should be pursued for easier integration and trade. 
d. The impact of these STI policies on development of bio-innovation in the region 
e. Share lessons from the experiences of the countries which are at different stages with their STI 
policies and bioscience innovation and development.  
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f. Highlight areas that need urgent investment in capacity building, policy change.  
 
The essence of this policy study is to seek results that can be applied widely to solve problems of bio-
innovation in the region, share cross-country experiences, foster networking and learning among the 
national Councils and Commissions for science and technology with other policy actors in the region, and 
provide quality advice to governments based on robust results. The study will be conducted hand in hand 
with ATPS. The study will involve engaging with relevant stakeholders (including government 
departments, policy actors, practitioners, private sector, civil society and journalists/media) in identifying 
and prioritizing specific research and policy questions to be addressed in each member country. The 
country-level analyses will be compared and contrasted to give a regional outlook on the status of STI 
policies in the region and their effect on bio-innovation. The findings of the study will be disseminated 
and shared during a planned high-level regional conference on bio-innovation in the third year of the 
project.  
 
1.3 Review the seed certification system in Eastern Africa  
 
The seed certification system in Eastern African still possesses enormous challenges to scientists wishing 
to commercialize or exchange novel or value added seed varieties in the region. Previous efforts by 
ASARECA to rationalize the regulatory and legal framework governing the seed industry have not borne 
the expected fruit and the industry remains small, fragmented and fraught with bottlenecks. This is 
evidenced by the shortage of planting seed and increasing imports of seed into the region to compensate 
for the persistent shortfalls. Since a number of BioInnovate projects have seed related products, policy 
related support in terms of harmonized seed certification procedures and protocols is necessary. The seed 
certification system in region will be reviewed. The review will involve interviews with actors in the seed 
industry as well as Bioinnovate project partners working on seed systems.  The review will establish 
status of seed certification in Eastern African with regard to the procedures and seed policies, and 
challenges this is posing to seed trade and germplasm exchange at the regional level. Based on this review 
a protocol to facilitate seed certification in Eastern Africa will be developed. The protocol will include 
regional certification standards, procedures for variety releases, registration, export and import into the 
BioInnovate participating countries.  
 
1.4 Review biosafety frameworks of the Eastern African countries   
 
Eastern African countries‟ national biosafety frameworks are at different levels of development and 
implementation. Though current Bio-Innovate projects are not working with genetically modified 
organisms, a functional biosafety framework in the country is essential for advancing bioscience 
innovations overall. This study will establish the status of biosafety development in the region and 
identify areas where harmonization of biosafety policies may be required. The review shall include the 
recently adopted Nagoya-Kuala Lumpur Protocol on liability and redress related to biological safety. 
Countries in Eastern Africa are making steps to domesticate this agreement, which will potentially have 
major impact on bioscience innovations in the region.  
 
1.5 Review the access and benefit sharing regime Eastern Africa to establish extent to which they support 
(hinder) exchange of biological materials and products  
 
This will involve an intensive analysis of the state of implementation of the multilateral system for access 
and benefit sharing under the International Treaty on Plant Genetic Resources for Food and Agriculture 
(ITPGRFA) in Eastern Africa and whether its objectives are being achieved or not at the national and 
institutional level. The analysis will also include the national PGRFA access systems such as 
arrangements with private plant breeding companies and the further transfer of PGRFA accessed under 
the standard material transfer agreement (SMTA). The study will help explore and identify options for 
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accessing materials such as use of bio-cultural protocols and other instruments to develop terms and 
procedures for accessing materials held by local communities and options for benefit sharing such as 
through participatory plant breeding and other collaborative projects; and private partnerships to access 
privately held material. Following this analysis a strategy on how best to access materials for the project 
partners will be identified.   
 
 Objective 2: To establish a platform/forum for interaction and exchange of ideas on bioscience 
innovations and policies in Eastern Africa 
 
2.2 Hold 3 annual national round-tables on bioscience innovations and policy issues in all Bio-Innovate 
countries 
 
These will be country level forums involving a range of actors in the bioscience innovation system such 
as academia, policy makers, business developers and entrepreneurs and the media. These policy round 
tables will be planned for between 50 and 70 participants once every four months in all the six countries. 
They will also involve BioInnovate partners within each country, and may be used an opportunity to 
create synergies between BioInnovate projects and national programmes, as well as advocacy and product 
development partnerships. These round tables will also be useful, among other things, in identifying 
policy issues as well as on building consensus on how to address those issues. These dialogues which 
may be one to two days will be convened by the national councils and commissions for science and 
technology in each country.  
 
2.3 Hold 9 partnership (breakfast) meetings in all Bio-Innovate countries targeting key players such as 
Parliamentary committees on S&T, professional bodies, business associations, entrepreneurs and 
academia) 
 
These will be smaller more targeted meetings aimed primarily at influencing policy change and building 
partnerships for product innovations and enterprise development. The stakeholders for these types of 
meetings will be business executives, high level policy makers, parliamentarians, science professions, 
academia, etc. These partnership meetings will be driven mainly by the policy needs of the BioInnovate 
project partners in each country. In other words, the BioInnovate project teams will work with the 
Councils and Commissions of science and technology in their  
Objective 3: To establish a forum for communication, dialogue and advocacy on bioscience policy issues 
in the region   
 
3.6 Develop in a participatory manner 12 institutional IP policies for Bio-Innovate organizations that 
lack them.  
 
This will be a participatory process that will involve identification of the organizations that do not have IP 
policies and working with the IP teams within the Projects to develop IP policies for these institutions. 
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Project Title: Biosciences Innovation Policy Consortium for Eastern Africa (BIPCEA)  
  
Partner Institution: Directorate of Science, Technology and Research, Rwanda (DSTR) 
 
Description of project Activities  
 
Objective 1: To identify and analyze policy issues essential for the success of BioInnovate supported 
projects  
 
1.1 Carry out four (4) case studies of Bio-Innovate projects to identify policy gaps and needs of 
BioInnovate projects. 
 
Four (4) case studies of Bio-Innovate projects in the region will be carried out to systematically establish 
the policy gaps and needs of BioInnovate Project. The case studies will be on projects that represent a 
combination of crop and environmental bioscience innovations, and geographical balance of BioInnovate 
partner countries. Some of these projects include, for example: 
 Project 1: Delivering new sorghum and millets innovations for food security and improving 
livelihoods 
 Project 2:  Enhancing food security through improved seed systems and varieties of cassava, 
potato and sweet potato resilient to climate change 
 Project 4: Sustainable utilization of agro-industrial wastes through integration of bio-energy and 
mushroom production 
 Project 5:  Integrated process for sustainable agro-process waste treatment and climate change 
mitigation 
 
We will use a Technological Innovation Systems (TIS) analytical framework for the case studies as most 
of them look to developing products and/or processes. The TIS is suitable because it enables analysis of 
the interactions among actors; and will entail a critical assessment of the knowledge base and diffusion, a 
review of relevant regional and national policies, entrepreneurial activities, potential markets, resource 
availability, acceptability of the innovations, and partnerships and networks which support bioscience 
innovation projects. Based on the TIS analysis, the Project team will determine strategies to address 
identified gaps and needs, and foster linkages among key actors.  
 
1.2 Review national science, technology and innovation policies in Eastern Africa to establish the extent 
to which they promote bioscience innovations  
 
While the integration of the East African Community is opening up political, economic and social 
development cooperation, the lack of policy coherence in areas such as bio-innovation are likely to 
remain a challenge to this process. It is important, therefore, that strategic science, technology and 
innovation policy studies are conducted across the region to underscore: 
 
a. Whether or not the countries have appropriate STI policies that support the development, uptake 
and commercialization of bio-innovations. 
b. The interaction between these STI policies with other relevant economic and social development 
policies e.g. economic planning, competition policies. Etc. 
c. Areas where harmonization of STI policies should be pursued for easier integration and trade. 
d. The impact of these STI policies on development of bio-innovation in the region 
e. Share lessons from the experiences of the countries which are at different stages with their STI 
policies and bioscience innovation and development.  
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f. Highlight areas that need urgent investment in capacity building, policy change.  
 
The essence of this policy study is to seek results that can be applied widely to solve problems of bio-
innovation in the region, share cross-country experiences, foster networking and learning among the 
national Councils and Commissions for science and technology with other policy actors in the region, and 
provide quality advice to governments based on robust results. The study will be conducted hand in hand 
with ATPS. The study will involve engaging with relevant stakeholders (including government 
departments, policy actors, practitioners, private sector, civil society and journalists/media) in identifying 
and prioritizing specific research and policy questions to be addressed in each member country. The 
country-level analyses will be compared and contrasted to give a regional outlook on the status of STI 
policies in the region and their effect on bio-innovation. The findings of the study will be disseminated 
and shared during a planned high-level regional conference on bio-innovation in the third year of the 
project.  
 
1.3 Review the seed certification system in Eastern Africa  
 
The seed certification system in Eastern African still possesses enormous challenges to scientists wishing 
to commercialize or exchange novel or value added seed varieties in the region. Previous efforts by 
ASARECA to rationalize the regulatory and legal framework governing the seed industry have not borne 
the expected fruit and the industry remains small, fragmented and fraught with bottlenecks. This is 
evidenced by the shortage of planting seed and increasing imports of seed into the region to compensate 
for the persistent shortfalls. Since a number of BioInnovate projects have seed related products, policy 
related support in terms of harmonized seed certification procedures and protocols is necessary. The seed 
certification system in region will be reviewed. The review will involve interviews with actors in the seed 
industry as well as Bioinnovate project partners working on seed systems.  The review will establish 
status of seed certification in Eastern African with regard to the procedures and seed policies, and 
challenges this is posing to seed trade and germplasm exchange at the regional level. Based on this review 
a protocol to facilitate seed certification in Eastern Africa will be developed. The protocol will include 
regional certification standards, procedures for variety releases, registration, export and import into the 
BioInnovate participating countries.  
 
1.4 Review biosafety frameworks of the Eastern African countries   
 
Eastern African countries‟ national biosafety frameworks are at different levels of development and 
implementation. Though current Bio-Innovate projects are not working with genetically modified 
organisms, a functional biosafety framework in the country is essential for advancing bioscience 
innovations overall. This study will establish the status of biosafety development in the region and 
identify areas where harmonization of biosafety policies may be required. The review shall include the 
recently adopted Nagoya-Kuala Lumpur Protocol on liability and redress related to biological safety. 
Countries in Eastern Africa are making steps to domesticate this agreement, which will potentially have 
major impact on bioscience innovations in the region.  
 
1.5 Review the access and benefit sharing regime Eastern Africa to establish extent to which they support 
(hinder) exchange of biological materials and products  
 
This will involve an intensive analysis of the state of implementation of the multilateral system for access 
and benefit sharing under the International Treaty on Plant Genetic Resources for Food and Agriculture 
(ITPGRFA) in Eastern Africa and whether its objectives are being achieved or not at the national and 
institutional level. The analysis will also include the national PGRFA access systems such as 
arrangements with private plant breeding companies and the further transfer of PGRFA accessed under 
the standard material transfer agreement (SMTA). The study will help explore and identify options for 
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accessing materials such as use of bio-cultural protocols and other instruments to develop terms and 
procedures for accessing materials held by local communities and options for benefit sharing such as 
through participatory plant breeding and other collaborative projects; and private partnerships to access 
privately held material. Following this analysis a strategy on how best to access materials for the project 
partners will be identified.   
 
 Objective 2: To establish a platform/forum for interaction and exchange of ideas on bioscience 
innovations and policies in Eastern Africa 
 
2.2 Hold 3 annual national round-tables on bioscience innovations and policy issues in all Bio-Innovate 
countries 
 
These will be country level forums involving a range of actors in the bioscience innovation system such 
as academia, policy makers, business developers and entrepreneurs and the media. These policy round 
tables will be planned for between 50 and 70 participants once every four months in all the six countries. 
They will also involve BioInnovate partners within each country, and may be used an opportunity to 
create synergies between BioInnovate projects and national programmes, as well as advocacy and product 
development partnerships. These round tables will also be useful, among other things, in identifying 
policy issues as well as on building consensus on how to address those issues. These dialogues which 
may be one to two days will be convened by the national councils and commissions for science and 
technology in each country.  
 
2.3 Hold 9 partnership (breakfast) meetings in all Bio-Innovate countries targeting key players such as 
Parliamentary committees on S&T, professional bodies, business associations, entrepreneurs and 
academia) 
 
These will be smaller more targeted meetings aimed primarily at influencing policy change and building 
partnerships for product innovations and enterprise development. The stakeholders for these types of 
meetings will be business executives, high level policy makers, parliamentarians, science professions, 
academia, etc. These partnership meetings will be driven mainly by the policy needs of the BioInnovate 
project partners in each country. In other words, the BioInnovate project teams will work with the 
Councils and Commissions of science and technology in their respective countries to identify the key 
actors they would want for the partnership meetings. These meetings would involve no more than twenty 
participants each time. 
 
2.4 Organizing one high-level regional policy conferences on bioscience innovations in Eastern Africa.  
 
These will be a regional conference which will, among other things, highlight the importance of working 
regionally to develop bioscience innovations, pooling expertise and sharing resources, and connecting to 
other institutions worldwide. The high level conference is planned for up to one hundred (150) 
participants from the region and abroad. It will include all BioInnovate project partners, policy makers, 
civil society representation and other regional bioscience related bodies and initiatives. The conference 
will be organized by the UNCST consultation with the BioInnovate Program manager. The conference 
shall specifically involve key decision makers from STI related ministries including the Ministries of 
Finance from each of the six countries in Eastern Africa as well as the East African Community. It is 
expected that such high level forum and the policy dialogue will present an opportunity for creating 
synergy between national programs and BioInnovate projects, enhance resource mobilization to support 
bioscience innovations, align BioInnovate interventions with national and regional development 
objectives, and help position biosciences among the region‟s top development priorities. 
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Objective 3: To establish a forum for communication, dialogue and advocacy on bioscience policy issues 
in the region   
 
3.6 Develop in a participatory manner 12 institutional IP policies for Bio-Innovate organizations that 
lack them.  
 
This will be a participatory process that will involve identification of the organizations that do not have IP 
policies and working with the IP teams within the Projects to develop IP policies for these institutions. 
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Project Title: Biosciences Innovation Policy Consortium for Eastern Africa (BIPCEA)  
  
Partner Institution: Tanzania Commission for Science and Technology (COSTECH) 
 
Description of project Activities  
 
Objective 1: To identify and analyze policy issues essential for the success of BioInnovate supported 
projects  
 
1.1 Carry out four (4) case studies of Bio-Innovate projects to identify policy gaps and needs of 
BioInnovate projects. 
 
Four (4) case studies of Bio-Innovate projects in the region will be carried out to systematically establish 
the policy gaps and needs of BioInnovate Project. The case studies will be on projects that represent a 
combination of crop and environmental bioscience innovations, and geographical balance of BioInnovate 
partner countries. Some of these projects include, for example: 
 Project 1: Delivering new sorghum and millets innovations for food security and improving 
livelihoods 
 Project 2:  Enhancing food security through improved seed systems and varieties of cassava, 
potato and sweet potato resilient to climate change 
 Project 4: Sustainable utilization of agro-industrial wastes through integration of bio-energy and 
mushroom production 
 Project 5:  Integrated process for sustainable agro-process waste treatment and climate change 
mitigation 
 
We will use a Technological Innovation Systems (TIS) analytical framework for the case studies as most 
of them look to developing products and/or processes. The TIS is suitable because it enables analysis of 
the interactions among actors; and will entail a critical assessment of the knowledge base and diffusion, a 
review of relevant regional and national policies, entrepreneurial activities, potential markets, resource 
availability, acceptability of the innovations, and partnerships and networks which support bioscience 
innovation projects. Based on the TIS analysis, the Project team will determine strategies to address 
identified gaps and needs, and foster linkages among key actors.  
 
1.2 Review national science, technology and innovation policies in Eastern Africa to establish the extent 
to which they promote bioscience innovations  
 
While the integration of the East African Community is opening up political, economic and social 
development cooperation, the lack of policy coherence in areas such as bio-innovation are likely to 
remain a challenge to this process. It is important, therefore, that strategic science, technology and 
innovation policy studies are conducted across the region to underscore: 
 
a. Whether or not the countries have appropriate STI policies that support the development, uptake 
and commercialization of bio-innovations. 
b. The interaction between these STI policies with other relevant economic and social development 
policies e.g. economic planning, competition policies. Etc. 
c. Areas where harmonization of STI policies should be pursued for easier integration and trade. 
d. The impact of these STI policies on development of bio-innovation in the region 
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e. Share lessons from the experiences of the countries which are at different stages with their STI 
policies and bioscience innovation and development.  
f. Highlight areas that need urgent investment in capacity building, policy change.  
 
The essence of this policy study is to seek results that can be applied widely to solve problems of bio-
innovation in the region, share cross-country experiences, foster networking and learning among the 
national Councils and Commissions for science and technology with other policy actors in the region, and 
provide quality advice to governments based on robust results. The study will be conducted hand in hand 
with ATPS. The study will involve engaging with relevant stakeholders (including government 
departments, policy actors, practitioners, private sector, civil society and journalists/media) in identifying 
and prioritizing specific research and policy questions to be addressed in each member country. The 
country-level analyses will be compared and contrasted to give a regional outlook on the status of STI 
policies in the region and their effect on bio-innovation. The findings of the study will be disseminated 
and shared during a planned high-level regional conference on bio-innovation in the third year of the 
project.  
 
1.3 Review the seed certification system in Eastern Africa  
 
The seed certification system in Eastern African still possesses enormous challenges to scientists wishing 
to commercialize or exchange novel or value added seed varieties in the region. Previous efforts by 
ASARECA to rationalize the regulatory and legal framework governing the seed industry have not borne 
the expected fruit and the industry remains small, fragmented and fraught with bottlenecks. This is 
evidenced by the shortage of planting seed and increasing imports of seed into the region to compensate 
for the persistent shortfalls. Since a number of BioInnovate projects have seed related products, policy 
related support in terms of harmonized seed certification procedures and protocols is necessary. The seed 
certification system in region will be reviewed. The review will involve interviews with actors in the seed 
industry as well as Bioinnovate project partners working on seed systems.  The review will establish 
status of seed certification in Eastern African with regard to the procedures and seed policies, and 
challenges this is posing to seed trade and germplasm exchange at the regional level. Based on this review 
a protocol to facilitate seed certification in Eastern Africa will be developed. The protocol will include 
regional certification standards, procedures for variety releases, registration, export and import into the 
BioInnovate participating countries.  
 
1.4 Review biosafety frameworks of the Eastern African countries   
 
Eastern African countries‟ national biosafety frameworks are at different levels of development and 
implementation. Though current Bio-Innovate projects are not working with genetically modified 
organisms, a functional biosafety framework in the country is essential for advancing bioscience 
innovations overall. This study will establish the status of biosafety development in the region and 
identify areas where harmonization of biosafety policies may be required. The review shall include the 
recently adopted Nagoya-Kuala Lumpur Protocol on liability and redress related to biological safety. 
Countries in Eastern Africa are making steps to domesticate this agreement, which will potentially have 
major impact on bioscience innovations in the region.  
 
1.5 Review the access and benefit sharing regime Eastern Africa to establish extent to which they support 
(hinder) exchange of biological materials and products  
 
This will involve an intensive analysis of the state of implementation of the multilateral system for access 
and benefit sharing under the International Treaty on Plant Genetic Resources for Food and Agriculture 
(ITPGRFA) in Eastern Africa and whether its objectives are being achieved or not at the national and 
institutional level. The analysis will also include the national PGRFA access systems such as 
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arrangements with private plant breeding companies and the further transfer of PGRFA accessed under 
the standard material transfer agreement (SMTA). The study will help explore and identify options for 
accessing materials such as use of bio-cultural protocols and other instruments to develop terms and 
procedures for accessing materials held by local communities and options for benefit sharing such as 
through participatory plant breeding and other collaborative projects; and private partnerships to access 
privately held material. Following this analysis a strategy on how best to access materials for the project 
partners will be identified.   
 
 Objective 2: To establish a platform/forum for interaction and exchange of ideas on bioscience 
innovations and policies in Eastern Africa 
 
2.2 Hold 3 annual national round-tables on bioscience innovations and policy issues in all Bio-Innovate 
countries 
 
These will be country level forums involving a range of actors in the bioscience innovation system such 
as academia, policy makers, business developers and entrepreneurs and the media. These policy round 
tables will be planned for between 50 and 70 participants once every four months in all the six countries. 
They will also involve BioInnovate partners within each country, and may be used an opportunity to 
create synergies between BioInnovate projects and national programmes, as well as advocacy and product 
development partnerships. These round tables will also be useful, among other things, in identifying 
policy issues as well as on building consensus on how to address those issues. These dialogues which 
may be one to two days will be convened by the national councils and commissions for science and 
technology in each country.  
 
2.3 Hold 9 partnership (breakfast) meetings in all Bio-Innovate countries targeting key players such as 
Parliamentary committees on S&T, professional bodies, business associations, entrepreneurs and 
academia) 
 
These will be smaller more targeted meetings aimed primarily at influencing policy change and building 
partnerships for product innovations and enterprise development. The stakeholders for these types of 
meetings will be business executives, high level policy makers, parliamentarians, science professions, 
academia, etc. These partnership meetings will be driven mainly by the policy needs of the BioInnovate 
project partners in each country. In other words, the BioInnovate project teams will work with the 
Councils and Commissions of science and technology in their respective countries to identify the key 
actors they would want for the partnership meetings. These meetings would involve no more than twenty 
participants each time. 
 
Objective 3: To establish a forum for communication, dialogue and advocacy on bioscience policy issues 
in the region   
 
3.6 Develop in a participatory manner 12 institutional IP policies for Bio-Innovate organizations that 
lack them.  
 
This will be a participatory process that will involve identification of the organizations that do not have IP 
policies and working with the IP teams within the Projects to develop IP policies for these institutions. 
 
3.8 Print and distribute 1500 laboratory note books to BioInnovate partner project teams 
Laboratory note books will be developed, printed and provided to bio-innovate research teams/scientists. 
This activity builds on the previous BIOEARN Project which demonstrated increased demand and value 
added in utilizing the laboratory note books among participating organizations. The essence of having 
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laboratory note books is to aide in patenting process should such possibility arise within the projects. 
Laboratory note books are a powerful tool to verify novelty claims during the patenting process. The 
Laboratory notebooks will be printed with a logo of the organization involved in the collaborative 
projects, and will be owned by the organization for which a scientist works.Project Title: Biosciences 
Innovation Policy Consortium for Eastern Africa (BIPCEA)  
  
Partner Institution: African Technology Policy Studies Network (ATPS) 
 
Description of project Activities  
 
Objective 1: To identify and analyze policy issues essential for the success of BioInnovate supported 
projects  
 
1.2 Review national science, technology and innovation policies in Eastern Africa to establish the extent 
to which they promote bioscience innovations  
 
While the integration of the East African Community is opening up political, economic and social 
development cooperation, the lack of policy coherence in areas such as bio-innovation are likely to 
remain a challenge to this process. It is important, therefore, that strategic science, technology and 
innovation policy studies are conducted across the region to underscore: 
 
a. Whether or not the countries have appropriate STI policies that support the development, uptake 
and commercialization of bio-innovations. 
b. The interaction between these STI policies with other relevant economic and social development 
policies e.g. economic planning, competition policies. Etc. 
c. Areas where harmonization of STI policies should be pursued for easier integration and trade. 
d. The impact of these STI policies on development of bio-innovation in the region 
e. Share lessons from the experiences of the countries which are at different stages with their STI 
policies and bioscience innovation and development.  
f. Highlight areas that need urgent investment in capacity building, policy change.  
 
The essence of this policy study is to seek results that can be applied widely to solve problems of bio-
innovation in the region, share cross-country experiences, foster networking and learning among the 
national Councils and Commissions for science and technology with other policy actors in the region, and 
provide quality advice to governments based on robust results. ATPS will work hand in hand with the 
Councils and Commissions for S&T to conduct this study. The study will involve engaging with relevant 
stakeholders (including government departments, policy actors, practitioners, private sector, civil society 
and journalists/media) in identifying and prioritizing specific research and policy questions to be 
addressed in each member country. The country-level analyses will be compared and contrasted to give a 
regional outlook on the status of STI policies in the region and their effect on bio-innovation. The 
findings of the study will be disseminated and shared during a planned high-level regional conference on 
bio-innovation in the third year of the project.  
 
 
Objective 3: To establish a forum for communication, dialogue and advocacy on bioscience policy issues 
in the region   
 
3.1 Develop a training manual on entrepreneurship  
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This will involve the development of guidelines, processes, and procedures for conducting 
entrepreneurship training for prospective BioInnovate scientists and practitioners. It will provide the 
necessary tools for starters and the necessary requirements for successful entrepreneurship. 
 
3.2 Train 150 scientists in entrepreneurship skills (including technology licensing agreements and 
business plan development) 
 
A training workshop will be convened for BioInnovate scientists/researchers to enable them gain skills on 
the best practices in enterprise establishment, management and operations. This will include training on 
making  techno-economic feasibility studies on technology dissemination Each training workshop is to be 
attended by up to 50 participants. The training will include, among others, issues on enterprise due 
diligence, technology licensing and business plan development.  
 
3.5 Train 80 BioInnovate scientists on IP  
 
The lack of IP awareness coupled with weak institutional mechanisms for IP management are 
constraining the development and dissemination of bioscience innovations in Eastern Africa. While the 
Bio-Earn Project, which is a predecessor to the current Bio-innovate program, spearheaded the 
development of institutional IP regimes in some of the organizations which were part of the program, 
these regimes have not been sufficiently utilized because of limited awareness and capacity of scientists 
on IP matters. Based on the planned assessment of intellectual assets of the bio-innovate partner 
organizations, as well as the freedom-to-operate a one week-long training for up to eighty (80) 
participants including researchers, policymakers, IP managers, research managers in the BioInnovate 
partner organizations will be conducted. This activity will draw experiences from ATPS‟ previous work 
on strengthening national IP policy and legal frameworks in East and Southern Africa.   
 
 
 
Project Title: Biosciences Innovation Policy Consortium for Eastern Africa (BIPCEA)  
  
Partner Institution: International Service for the Acquisition of Agri-Biotech Applications (ISAAA) 
 
Description of project Activities  
 
Objective 1: To identify and analyze policy issues essential for the success of BioInnovate supported 
projects  
 
1.3 Review the seed certification system in Eastern Africa  
 
The seed certification system in Eastern African still possesses enormous challenges to scientists wishing 
to commercialize or exchange novel or value added seed varieties in the region. Previous efforts by 
ASARECA to rationalize the regulatory and legal framework governing the seed industry have not borne 
the expected fruit and the industry remains small, fragmented and fraught with bottlenecks. This is 
evidenced by the shortage of planting seed and increasing imports of seed into the region to compensate 
for the persistent shortfalls. Since a number of BioInnovate projects have seed related products, policy 
related support in terms of harmonized seed certification procedures and protocols is necessary. The seed 
certification system in region will be reviewed. The review will involve interviews with actors in the seed 
industry as well as Bioinnovate project partners working on seed systems.  The review will establish 
status of seed certification in Eastern African with regard to the procedures and seed policies, and 
challenges this is posing to seed trade and germplasm exchange at the regional level. Based on this review 
41 
 
a protocol to facilitate seed certification in Eastern Africa will be developed. The protocol will include 
regional certification standards, procedures for variety releases, registration, export and import into the 
BioInnovate participating countries.  
 
1.4 Review biosafety frameworks of the Eastern African countries   
 
Eastern African countries‟ national biosafety frameworks are at different levels of development and 
implementation. Though current Bio-Innovate projects are not working with genetically modified 
organisms, a functional biosafety framework in the country is essential for advancing bioscience 
innovations overall. This study will establish the status of biosafety development in the region and 
identify areas where harmonization of biosafety policies may be required. The review shall include the 
recently adopted Nagoya-Kuala Lumpur Protocol on liability and redress related to biological safety. 
Countries in Eastern Africa are making steps to domesticate this agreement, which will potentially have 
major impact on bioscience innovations in the region.  
 
 
 Objective 2: To establish a platform/forum for interaction and exchange of ideas on bioscience 
innovations and policies in Eastern Africa 
 
2.1 Undertake a BIPCEA and BioInnovate Projects stakeholder analysis and map potential strategic 
partners for advancing biosciences innovations in Eastern Africa. 
 
An intensive stakeholder analysis and netmapping exercise to identify key stakeholders, and audiences in 
the BIPCEA project will be conducted. This will be done by BIPCEA team members through a 
brainstorming session during which all the stakeholders will be categorized according to their interest and 
power. „Interest‟ will be a measure of the degree they are likely to be affected by the project or policy 
change, and what degree of interest or concern they have in or about it. „Power‟ will be a measure of the 
influence they have over the project or policy, and to what degree they can help achieve, or block, the 
desired change. This analysis will also help in understanding groups that advocate or oppose scientific 
innovations taking into account the threats and opportunities that such groups present. Following this 
analysis a strategy on how best to engage and sustain relationships with the different stakeholders in the 
project will be identified. This will be done by bringing together all the identified strategic stakeholders in 
a workshop during which mechanisms and strategies on how to link actors in the bioscience innovation 
system will be identified and agreed on. 
 
2.5 Have media coverage on key events 
 
This entails maintaining a sustained engagement of the media through innovative ways and means. This 
will involve identifying key events such as the ones aforementioned, representing significant 
opportunities for strategic communication to stakeholders. Some of the media coverage events and 
engagement strategies will include news conferences, releases, press briefings, feature articles, opinion 
pieces, news advisories, calls to journalists informing them of key events and photo opportunities among 
others. 
 
2.6 Develop four (4) sets of bioscience policy communication materials with key messages 
 
This will involve the development of appropriate range of robust and compelling communication 
materials to promote policy information emanating from the project. Strategic targeting and consistency 
will be key to project‟s messages.  Several tools and activities informed by the key audiences, messages, 
or a combination of the two will be used. These will include policy briefs, special papers, working papers 
and message maps.  A core message that will act as the central piece of information that BIPCEA aims to 
42 
 
communicate to target audiences through every activity will be developed. It will provide a quick way of 
capturing attention and communicating outcomes. This will be a simple, realistic and memorable message 
that can be repeated severally to create understanding, acceptance and lead to ultimate success of the 
BioInnovate projects project efforts. 
 
Objective 3: To establish a forum for communication, dialogue and advocacy on bioscience policy issues 
in the region   
 
3.7 Train 100 scientists on how to reach policymakers with their research findings   
 
Training workshops for scientist involved in the BioInnovate funded projects will be held in the 6 study 
countries. The objectives of the workshops will be to: i) equip the scientists with communications skills 
for effective engagement of policy makers; ii) Sharpen the skills of Principal Investigators (PIs) and 
project‟s communication personnel on media relations and issue-management; and equip scientists with 
skills to design and package comprehensive communication messages on the project including 
preparation of policy papers, special papers, working papers and message maps. 
 
 
 
 
Project Title: Biosciences Innovation Policy Consortium for Eastern Africa (BIPCEA)  
  
Partner Institution: International Livestock Research Institute (ILRI) 
 
Description of project Activities  
 
Objective 1: To identify and analyze policy issues essential for the success of BioInnovate supported 
projects  
 
1.5 Review the access and benefit sharing regime Eastern Africa to establish extent to which they support 
(hinder) exchange of biological materials and products  
 
This will involve an intensive analysis of the state of implementation of the multilateral system for access 
and benefit sharing under the International Treaty on Plant Genetic Resources for Food and Agriculture 
(ITPGRFA) in Eastern Africa and whether its objectives are being achieved or not at the national and 
institutional level. The analysis will also include the national PGRFA access systems such as 
arrangements with private plant breeding companies and the further transfer of PGRFA accessed under 
the standard material transfer agreement (SMTA). The study will help explore and identify options for 
accessing materials such as use of bio-cultural protocols and other instruments to develop terms and 
procedures for accessing materials held by local communities and options for benefit sharing such as 
through participatory plant breeding and other collaborative projects; and private partnerships to access 
privately held material. Following this analysis a strategy on how best to access materials for the project 
partners will be identified.   
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 Objective 3: To establish a forum for communication, dialogue and advocacy on bioscience policy 
issues in the region   
 
3.3 Develop intellectual property management tools for all Bio-Innovate partner projects. 
 
This will involve the development and distribution to project partners of a „common IP operational 
framework‟ the purpose of which is to provide common IP management processes for BioInnovate 
project partners. The framework will provide Guiding Principles on the identification, monitoring and 
management of their IP assets to enable the projects to capitalize on the potential benefits. Project 
partners will be provided with the resources and tools required for the sound management of intellectual 
assets in accordance with best practices to facilitate in making more informed decisions, such as acquiring 
other intellectual property assets (licensing in) or licensing out. 
 
3.4 Undertake a Freedom-to-Operate for Bio-Innovate projects 
 
This will be a participatory process involving the creation of IP teams within the projects to keep an 
inventory of third party IP used by the Project. An analysis of the final product will then be conducted to 
establish whether the product can be deployed without the risk of infringing existing third party rights.   
 
3.5 Train 80 BioInnovate scientists on IP  
 
The lack of IP awareness coupled with weak institutional mechanisms for IP management are 
constraining the development and dissemination of bioscience innovations in Eastern Africa. While the 
Bio-Earn Project, which is a predecessor to the current Bio-innovate program, spearheaded the 
development of institutional IP regimes in some of the organizations which were part of the program, 
these regimes have not been sufficiently utilized because of limited awareness and capacity of scientists 
on IP matters. Based on the planned assessment of intellectual assets of the bio-innovate partner 
organizations, as well as the freedom-to-operate a one week-long training for up to eighty (80) 
participants including researchers, policymakers, IP managers, research managers in the BioInnovate 
partner organizations will be conducted. This activity will draw experiences from ATPS‟ previous work 
on strengthening national IP policy and legal frameworks in East and Southern Africa.   
 
3.6 Develop in a participatory manner 12 institutional IP policies for Bio-Innovate organizations that 
lack them.  
 
This will be a participatory process that will involve identification of the organizations that do not have IP 
policies and working with the IP teams within the Projects to develop IP policies for these institutions. 
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Project Title: Biosciences Innovation Policy Consortium for Eastern Africa (BIPCEA)  
  
Partner Institution: Stockholm Environment Institute (SEI) 
 
NB. SEI will mainly provide technical support/backstopping for the activities described below.  
 
Description of project Activities  
 
Objective 1: To identify and analyze policy issues essential for the success of BioInnovate supported 
projects  
 
1.1 Carry out four (4) case studies of Bio-Innovate projects to identify policy gaps and needs of 
BioInnovate projects. 
 
Four (4) case studies of Bio-Innovate projects in the region will be carried out to systematically establish 
the policy gaps and needs of BioInnovate Project. The case studies will be on projects that represent a 
combination of crop and environmental bioscience innovations, and geographical balance of BioInnovate 
partner countries. Some of these projects include, for example: 
 Project 1: Delivering new sorghum and millets innovations for food security and improving 
livelihoods 
 Project 2:  Enhancing food security through improved seed systems and varieties of cassava, 
potato and sweet potato resilient to climate change 
 Project 4: Sustainable utilization of agro-industrial wastes through integration of bio-energy and 
mushroom production 
 Project 5:  Integrated process for sustainable agro-process waste treatment and climate change 
mitigation 
 
We will use a Technological Innovation Systems (TIS) analytical framework for the case studies as most 
of them look to developing products and/or processes. The TIS is suitable because it enables analysis of 
the interactions among actors; and will entail a critical assessment of the knowledge base and diffusion, a 
review of relevant regional and national policies, entrepreneurial activities, potential markets, resource 
availability, acceptability of the innovations, and partnerships and networks which support bioscience 
innovation projects. Based on the TIS analysis, the Project team will determine strategies to address 
identified gaps and needs, and foster linkages among key actors.  
 
1.2 Review national science, technology and innovation policies in Eastern Africa to establish the extent 
to which they promote bioscience innovations  
 
While the integration of the East African Community is opening up political, economic and social 
development cooperation, the lack of policy coherence in areas such as bio-innovation are likely to 
remain a challenge to this process. It is important, therefore, that strategic science, technology and 
innovation policy studies are conducted across the region to underscore: 
 
a. Whether or not the countries have appropriate STI policies that support the development, uptake 
and commercialization of bio-innovations. 
b. The interaction between these STI policies with other relevant economic and social development 
policies e.g. economic planning, competition policies. Etc. 
c. Areas where harmonization of STI policies should be pursued for easier integration and trade. 
d. The impact of these STI policies on development of bio-innovation in the region 
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e. Share lessons from the experiences of the countries which are at different stages with their STI 
policies and bioscience innovation and development.  
f. Highlight areas that need urgent investment in capacity building, policy change.  
 
The essence of this policy study is to seek results that can be applied widely to solve problems of bio-
innovation in the region, share cross-country experiences, foster networking and learning among the 
national Councils and Commissions for science and technology with other policy actors in the region, and 
provide quality advice to governments based on robust results. The Councils and Commissions for S&T 
will work hand in hand with ATPS to conduct this study. The study will involve engaging with relevant 
stakeholders (including government departments, policy actors, practitioners, private sector, civil society 
and journalists/media) in identifying and prioritizing specific research and policy questions to be 
addressed in each member country. The country-level analyses will be compared and contrasted to give a 
regional outlook on the status of STI policies in the region and their effect on bio-innovation. The 
findings of the study will be disseminated and shared during a planned high-level regional conference on 
bio-innovation in the third year of the project.  
 
1.3 Review the seed certification system in Eastern Africa  
 
The seed certification system in Eastern African still possesses enormous challenges to scientists wishing 
to commercialize or exchange novel or value added seed varieties in the region. Previous efforts by 
ASARECA to rationalize the regulatory and legal framework governing the seed industry have not borne 
the expected fruit and the industry remains small, fragmented and fraught with bottlenecks. This is 
evidenced by the shortage of planting seed and increasing imports of seed into the region to compensate 
for the persistent shortfalls. Since a number of BioInnovate projects have seed related products, policy 
related support in terms of harmonized seed certification procedures and protocols is necessary. The seed 
certification system in region will be reviewed. The review will involve interviews with actors in the seed 
industry as well as Bioinnovate project partners working on seed systems.  The review will establish 
status of seed certification in Eastern African with regard to the procedures and seed policies, and 
challenges this is posing to seed trade and germplasm exchange at the regional level. Based on this review 
a protocol to facilitate seed certification in Eastern Africa will be developed. The protocol will include 
regional certification standards, procedures for variety releases, registration, export and import into the 
BioInnovate participating countries.  
 
1.4 Review biosafety frameworks of the Eastern African countries   
 
Eastern African countries‟ national biosafety frameworks are at different levels of development and 
implementation. Though current Bio-Innovate projects are not working with genetically modified 
organisms, a functional biosafety framework in the country is essential for advancing bioscience 
innovations overall. This study will establish the status of biosafety development in the region and 
identify areas where harmonization of biosafety policies may be required. The review shall include the 
recently adopted Nagoya-Kuala Lumpur Protocol on liability and redress related to biological safety. 
Countries in Eastern Africa are making steps to domesticate this agreement, which will potentially have 
major impact on bioscience innovations in the region.  
 
1.5 Review the access and benefit sharing regime Eastern Africa to establish extent to which they support 
(hinder) exchange of biological materials and products  
 
This will involve an intensive analysis of the state of implementation of the multilateral system for access 
and benefit sharing under the International Treaty on Plant Genetic Resources for Food and Agriculture 
(ITPGRFA) in Eastern Africa and whether its objectives are being achieved or not at the national and 
institutional level. The analysis will also include the national PGRFA access systems such as 
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arrangements with private plant breeding companies and the further transfer of PGRFA accessed under 
the standard material transfer agreement (SMTA). The study will help explore and identify options for 
accessing materials such as use of bio-cultural protocols and other instruments to develop terms and 
procedures for accessing materials held by local communities and options for benefit sharing such as 
through participatory plant breeding and other collaborative projects; and private partnerships to access 
privately held material. Following this analysis a strategy on how best to access materials for the project 
partners will be identified.   
 
 Objective 2: To establish a platform/forum for interaction and exchange of ideas on bioscience 
innovations and policies in Eastern Africa 
 
2.4 Organizing two high-level regional policy conferences on bioscience innovations in Eastern Africa.  
 
These will be regional conferences which will, among other things, highlight the importance of working 
regionally to develop bioscience innovations, pooling expertise and sharing resources, and connecting to 
other institutions worldwide. Each of these high level conferences is planned for up to one hundred (150) 
participants from the region and abroad. They will include all BioInnovate project partners, policy 
makers, civil society representation and other regional bioscience related bodies and initiatives. These 
conferences will be organized by the Councils and Commissions for S&T in consultation with the 
BioInnovate Program manager. One of these regional conferences shall specifically involve Government 
ministers and key decision makers from STI related ministries including the Ministries of Finance from 
each of the six countries in Eastern Africa as well as the East African Community. It is expected that such 
high level forum and the policy dialogues will present an opportunity for creating synergy between 
national programs and BioInnovate projects, enhance resource mobilization to support bioscience 
innovations, align BioInnovate interventions with national and regional development objectives, and help 
position biosciences among the region‟s top development priorities. 
 
2.7 Prepare a flagship publication on bioscience innovation system and the emerging bio-economy in 
Eastern Africa 
 
The study reports together with the high level regional conference proceedings would result in a printed 
volume or BioInnovate flagship publication presenting case-study experiences, lessons learned, and 
prospects for and anticipated impact of current and future bioscience innovations. The book will deal with 
how bioscience innovations, and in particular the BioInnovate project will contribute to a more profitable, 
climate smart and resource efficient economy, and include an analysis of potential future socio economic 
impacts of current and planned bioscience innovation investments. It is expected that book would be 
launched in towards the end of the third year of BIPCEA. Efforts will be made to engage regional and 
international publishers to print and disseminate this publication to a large audience. 
 
Objective 3: To establish a forum for communication, dialogue and advocacy on bioscience policy issues 
in the region   
 
3.3 Develop intellectual property management tools for all Bio-Innovate partner projects. 
 
This will involve the development and distribution to project partners of a „common IP operational 
framework‟ the purpose of which is to provide common IP management processes for BioInnovate 
project partners. The framework will provide Guiding Principles on the identification, monitoring and 
management of their IP assets to enable the projects to capitalize on the potential benefits. Project 
partners will be provided with the resources and tools required for the sound management of intellectual 
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assets in accordance with best practices to facilitate in making more informed decisions, such as acquiring 
other intellectual property assets (licensing in) or licensing out. 
 
3.4 Undertake a Freedom-to-Operate for Bio-Innovate projects 
 
This will be a participatory process involving the creation of IP teams within the projects to keep an 
inventory of third party IP used by the Project. An analysis of the final product will then be conducted to 
establish whether the product can be deployed without the risk of infringing existing third party rights.   
 
3.6 Develop in a participatory manner 12 institutional IP policies for Bio-Innovate organizations that 
lack them.  
 
This will be a participatory process that will involve identification of the organizations that do not have IP 
policies and working with the IP teams within the Projects to develop IP policies for these institutions. 
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20. Project logframe 
 
A logical framework matrix (logframe) following the template provided by the BioInnovate 
management team, is included as Annex 1. 
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Annex 1. Logical framework 
 
Project goal: to provide policy support services that will enable BioInnovate projects in Eastern Africa to successfully bring their technologies 
and business ideas to market. 
Outputs Outcome Outcome indicator Data source Collection 
method 
Assumptions  
Project objectives 
Objective 1: To identify and analyze policy issues essential for the success of BioInnovate supported projects 
 
1.1Four (4) case study reports on 
Bio-Innovate projects.  
Bio-Innovate partner 
organizations encounter less 
policy related obstacles in the 
process of developing and 
commercializing their 
bioscience innovations;  
 
Policies, strategies and actions 
to promote bioscience 
innovations more prominent in 
the policy and development 
agenda in Eastern Africa. 
 
Reported bioscience policy 
related challenges actively 
addressed  and significantly 
reduced by end of 2014. 
 
 
 
Investment in bioscience 
innovations increased by at 
least 25% by end of 2014 
Firms and 
organizations 
reports 
 
 
 
 
Organization‟s 
budgets; budget 
speeches 
Surveys of firms 
and 
organizations 
 
 
 
 
Document 
review; 
1. Government commitment to 
STI is sustained 
2. Selected bioscience 
innovations are economically 
and environmentally 
affordable and sustainable 
1.2A report on review of national 
STI policies in EA. 
1.3A report on the seed 
certification system in EA. 
1.4A protocol to facilitate seed 
certification in Eastern Africa. 
1.5A report on biosafety 
frameworks of EA countries. 
1.6A report on access and benefit 
sharing regime in EA. 
1.7Three (3) policy briefs from the 
above studies. 
1.8Two (2) journal articles from 
the above studies. 
Objective 2:  To establish a platform/forum for interaction and exchange of ideas on bioscience innovations and policies in Eastern 
Africa 
 
2.1Proceedings of a workshop on a 
BIPCEA and BioInnovate Projects 
stakeholder analysis and mapping. 
Policies, strategies and actions 
to promote bioscience 
innovations more prominent in 
the policy and development 
agenda in Eastern Africa. 
. 
 
Investment in bioscience 
innovations increased by at 
least by end of 2014 
 
Firms and 
organizations 
reports 
 
Organization‟s 
budgets; budget 
speeches 
Surveys of firms 
and 
organizations 
 
 
 
 
1. Government commitment to 
STI is sustained 
2. Selected bioscience 
innovations are economically 
and environmentally 
affordable and sustainable  
2.2Proceedings of two (2) high-
level regional conferences on 
bioscience innovations and 
policies in EA.  
2.3Eighteen (18) annual national 
round-tables on bioscience 
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innovations and policy issues in all 
Bio-Innovate countries. 
2.4Media coverage on key events. 
2.5Four (4) sets of bioscience 
policy communication materials 
with key messages  
2.6Fourty five (45) partnership 
(breakfast) meetings in all Bio-
Innovate countries. 
2.7One flagship publication on 
bioscience innovation system and 
the emerging bio-economy in EA. 
2.8A journal article from the 
above activities. 
Objective 3: To provide necessary policy support tools for biosciences innovations and related activities in the region 
 
3.1A training manual on 
entrepreneurship for BioInnovate 
projects. 
BioInnovate partner 
organizations manage the IP 
according to international best 
practice 
 
BioInnovate collaborating 
scientists increasingly bring 
their technologies to market. 
Filing for IP protection 
doubles in all BioInnovate 
partner organizations by end 
of 2014  
 
At least 20% of BioInnovate 
scientists prepare proposals for 
start-up bioscience companies  
Firms and 
organization 
reports;  
Document 
review 
1. Government commitment to 
STI is sustained 
2. Selected bioscience 
innovations are economically 
and environmentally 
affordable and sustainable  
3.2. One fifty (150) scientists 
trained in entrepreneurship skills 
3.3IP management tools for all 
Bio-Innovate partner 
organizations. 
3.4A report on Freedom-to-
Operate for Bio-Innovate projects. 
3.5. Eighty (80) Bio-Innovate 
scientists on IP. 
3.6. One hundred (100) scientists 
on science communication skills 
3.7 Twelve (12) institutional IP 
policies for Bio-Innovate 
organizations that lack them. 
3.8 One thousand five hundred 
(1500) lab note books printed and 
distributed to BioInnovate partner 
project teams. 
 
 Annex 2. Team leadership details  
 
(1) CV for Principal Investigator 
 
Name: Julius Ecuru  
Date of Birth: 4
th
 December 1973 
Nationality: Ugandan  
 
Education and Qualification 
2004-2006: University of Cape Town, South Africa: Postgraduate Diploma in International 
Research Ethics  
1999-2003: Makerere University, Kampala-Uganda: M.Sc. (Environmental Science)  
1994-1998: Makerere University, Kampala-Uganda: B.Sc. Honours (Chemistry)   
 
Short courses 
September -October 2006: Ghana Institute of Management and Public Administration, Accra, 
Ghana: Goods and Equipment Procurement Management, and Selection and 
Employment of Consultants 
September 2006: Inter-University Council for East Africa, Kampala, Uganda: Best Practices 
in Project Management  
 
Experience 
2005 – present: Assistant Executive Secretary and Head, Division of Research and 
Technology Development- Uganda National Council for Science and Technology, Uganda. 
Responsible for research and development policy management and oversight, management of 
science and innovation projects, ensuring human and environmental safety in the conduct of 
research, and institutional development planning.  
2006-2010: Co-Principal Investigator for an East African project on enhancing product 
development opportunities and supportive policies. Initiated processes for establishing 
policies that promote product development and commercialization of innovations, including 
management of intellectual property in selected organizations and strategic partnerships for 
uptake of innovations. 
Oct. 1, 2002- July 2004: Science and Technology Management Associate-Uganda National 
Council for Science and Technology, Uganda. Responsibilities included: research policy 
analysis, corporate management, international liaison in research and technology transfer, and 
intellectual property management.  
Aug. 2001 – 2005: National Focal Point Coordinator for the East African Research Network 
and Programme for Biotechnology, Biosafety and Biotechnology Policy Development (BIO-
EARN).  Assisted in developing Uganda‟s national policy on biotechnology, and establishing 
a functional biosafety system, as well as institutional mechanisms for technology transfer; 
also, conducted a series of public awareness programs on environmental and human health 
considerations of work involving potentially hazardous biological and chemical substances 
including recombinant DNA technology.  
 
Papers 
Ecuru, J., Okot-Okumu, J., and Okurut, O. T. (2011) Monitoring residual chlorine decay and 
coliform contamination in water distribution network of Kampala, Uganda. Journal of 
Applied Science and Environmental Management. March 2011. Vol 15 (1). 167-173. 
 Ecuru, J., Lating O.P, Ziraba N.Y., and Trojer L (2011) Integrating science, technology and 
innovation in national development planning process: the case of Uganda: In 
Proceedings of the 2
nd
 International Conference on Advances in Engineering and 
Technology, Entebbe, Uganda 
Ecuru, J., and Naluyima, H. (2010), Biotechnology development and associated challenges in 
Uganda. African Crop Science Journal, Vol. 18, No. 4. pp 133-139. 
Ecuru, J.,Nawegulo, L., Lutalo, R. B., Kasule, D., Tujunirwe, E., and Akampurira, I. (2008) 
Research in Uganda: status and implications for public policy, Uganda National 
Council for Science and Technology, Kampala 
Ecuru, J., Kingamkono, R.R., Omari, J., Ivar, V., and Komen, J. (2008) Intellectual property 
management, Policy Brief published by the Inter-University Council for East Africa 
Ecuru, J. (2004) An Overview of the status of biosafety in Uganda. In Proceedings of a 
National Awareness Workshop on Biosafety, Addis Ababa, Ethiopia, EPA 
 (2) CVs for co-PIs 
 
Margaret Karembu  
     
Nationality:  Kenyan 
Institution:   ISAAAA Africenter 
   P O Box 70, Uthiru, 00605 
    ILRI Campus, Old Naivasha Road. 
   Nairobi KENYA 
   Tel: 254 20 4223618/5; Cell Phone: 254 738159054  
   E-mail:  m.karembu@cgiar.org; m.karembu@isaaa.org 
 
Current Position 
  
Regional Director, International Service for the Acquisition of Agri-biotech Applications 
ISAAA Africenter, Nairobi, KENYA 
 
Responsibilities: Managing, implementing and coordinating selected ISAAA-facilitated 
technology transfer and communications‟ projects in Africa and carrying out needs 
assessment and technology diffusion studies on the newly emerging field of modern 
biotechnology. 
 
Specialty Areas: Environmental Science Education and Communications, Technology 
Transfer, Policy Outreach. 
Education: 
1. Ph.D. Environmental Science Education, Kenyatta University (2002) 
2. M.Ed. Environmental Studies - Kenyatta University (1990) 
3. B.Ed (Science) Kenyatta University, (1987). 
4. SI (Diploma eqv.) Science Teacher Education–Kenya Science Teachers College 
(1982) 
 
Recent selected short courses attended relevant to current project: 
 
(i) Champions for Change Leadership Course under USAID/CAADP- Comprehensive 
Africa Agriculture Development Program Capacity-building project March, 2011, 
Nairobi, Kenya. 
(ii) Strategic Leadership and Change Management for Directors of State Corporations, 
Kenya Institute of Administration, February 2011. 
(iii)Science, Technology and Innovation Policy Course at Harvard Kennedy School of 
Executive Education, Harvard, University, USA, 2009. 
 
Membership in Institutional and Professional Associations  
 
 Council Vice-Chair, Meru University College of Science and Technology 
 Open Forum on Agricultural Biotechnology in Africa (OFAB) 
 Kenya Network for Dissemination of Agricultural Technologies (KENDAT) 
 African Biotechnology Stakeholders Forum (ABSF) 
 Kenya National Biotechnology Awareness Creation Task Force (BIOAWARE) 
 African Council for Communication Education (ACCE) 
 
 TEKLEHAIMANOT HAILESELASSIE TEKLU 
Biotechnology Program 
Addis Ababa University (AAU), P.O.Box 1176 
Addis Ababa, Ethiopia 
Mobile: +251-911-198349 
E-mail: tekle1961@yahoo.com, teklehaimanot.haileselassie@gmail.com 
 
EDUCATION:  
2005  PhD in Biology, Lund University, Lund, Sweden 
2000   M.Sc. Lund University, Lund, Sweden (Ecology)  
1998   M.Sc. Addis Ababa University, Ethiopia (Biology)  
1983   B.Sc. Addis Ababa University, Ethiopia (Biology)  
 
WORK EXPERIENCE:  
Present Academic staff, Biotechnology Program, Faculty of Science.   
2008 – 10 Registrar, Addis Ababa University 
2007 – 08 Associate Dean for Business and Administration, Faculty of Science, AAU. 
1995 – 99  Research Associate, Addis Ababa University, Addis Ababa  
 
RESEARCH INTERESTS:  
Plant Ecology, Biosafety, Gene flow and hybridization between crop-to-wild/weedy relatives, 
and conservation biology.  
 
RESEARCH GRANT 
2005-2010 Gene flow from cultivated rice (Oriza sativa) to its AA genome wild relatives 
in the East African Region: key research for transgenic risk assessment 
supported by USAID through its Program for Biosafety Systems (PBS).  
 
SHORT TERM TRAINING/WORKSHOPS:  
27-30 November 2004: Natural hybridization and introgression: from genomics to ecology, 
Denmark.  
24 March- 11 April 2004: Genetically modified crop plants in practice- Biosafety and the 
route from gene to market, Svalöv, Sweden.  
3-7 June 2002: Introduction to biosafety and risk assessment for the environmental release of 
Genetically Modified Organisms (GMOs): Theoretical approach and scientific 
background, Trieste, Italy.  
8-22 June 2000: BIO-EARN course on Risk Evaluation of GMOs, Lund, Sweden.  
 
PUBLICATIONS:  
Haileselassie, T., Nkya, M. and Skogsmyr, I. (2005). Effects of nutrients on maternal choice 
and siring success in Cucumis sativus (Cucurbitaceae). Evolutionary Ecology: In 
press.  
Haileselassie, T. (2001). The effects of Environmental factors on male and female 
reproductive functions. Introductory Paper no. 127. 
 Name:   Ivar Virgin 
Date of Birth:  17th November 1961 
Nationality:   Swedish  
 
Education and Qualification 
 
 Jan 1993 - April 1994.  Postdoctoral Fellow, Institute fur Genforschung (IGF), Berlin, 
Germany 
Jan 1988 - May 1992 Ph.D. in Biochemistry, Stockholm University, Sweden 
 
Experience 
Dr.Ivar Virgin is a Senior Researcher at the Stockholm Environment Institute (SEI). He is 
also the Project Manager of the Biosafety and Biotechnology Policy Programme which is a 
part of the overall SEI Programme. For the past 15 years at SEI he has done extensive 
research and managed numerous projects in the field of biotechnology-biosafety, food safety, 
biodiversity, forest genetic resources, climate change, impacts/risks/costs/benefits of modern 
agricultural biotechnology, bioresources and innovation, Intellectual Property Rights (IPR) 
and access to genetic resources, water quality monitoring and EIA, especially related to 
environmental problems and capacity building and institutional building in third world 
countries. The work has primarily focused on Southern and Eastern Africa and South East 
Asia and but he has also worked in China, India and in Latin America. Responsibilities has 
covered expert level research and evaluation as well as all aspects of project management, 
such as project development, team selection and stakeholder involvement, implementing 
workplans, financial management and project evaluation.  
 
Dr Virgin has a Ph.D. in Biochemistry from Stockholm University. The thesis focused on the 
understanding of the molecular responses to stress in higher plants. During his Postdoctoral 
Fellowship at Institute fur Genforschung (IGF) in Berlin, Germany his research focused on 
the development of genetically modified crops producing modified starch for the utilisation 
as biodegradable packaging material. During his time at SEI he has also published 
extensively in the area of agricultural biotechnology technology transfer, cost/benefits of 
agricultural biotechnology, food safety, biosafety risk assessment and biosafety capacity 
building in developing countries (see below). Dr. Virgin has also developed and is managing 
the Sida supported East African Regional Programme and Research Network for 
Biotechnology, Biosafety and Biotechnology Policy Development (BIO-EARN). He has 
developed and is managing the SEI research project; Integrating Biosafety into Biotechnology 
Development: Comparative Analyses of Policies and Strategies in Asia and their 
Implications. He is also a founding partner of the Sida supported course and capacity building 
project; Genetic Resources and Intellectual Property Rights – Pathways for Development. 
 
Papers 
 
Francis X. Johnson and Ivar Virgin(2010) Future Trends In Biomass Resources For Food 
And Fuel. In An Informed Introduction to Biofuels, Edited by Frank Rosillo-Calle and Francis 
X. Johnson, ISBN: 9781848133822, a ZED book 
(www.zedbooks.co.uk/book.asp?bookdetail=4364) 
 
Virgin, I. Bhagavan, M. Komen, J. Kullaya, A., Louwaars E. N, Morris, J. Okori P. and 
Persley, G. (2007) Agricultural Biotechnology and Small-scale Farmers in Eastern and 
 Southern Africa (56pp) Stockholm Environment Institute, Stockholm, ISBN: 978-91-976022-
1.  
 
Indira, A., Bhagavan, M. and Virgin, I. Agricultural Biotechnology and Biosafety in India: 
Expectations, Outcomes and Lessons. 138 pp. Stockholm Environment Institute, Stockholm, 
ISBN 91 975238 01 
 
Bhagavan, M.R. and Virgin, I. (2004), Agricultural Biotechnology in Developing Countries: 
A Briefing Paper for Sida, (46 pp) Stockholm Environment Institute, Stockholm, ISBN 91 
88714 92 6.  
 
Virgin, Ivar (2002). Long-Term Strategies for Strengthening Agricultural Biotechnology 
Research and Development Capacity in Tanzania” (82 pp). Consultancy Report for the 
Department of Research and Development (DRD) and the Ministry of Agriculture and Food 
Security (MAFS) in Tanzania funded by the World Bank and TARP II project. Report well 
received by DRD/MAFS officials. 
 
 
Name:  Komen 
Christian names: Johannes Cornelis Everardus  (John) 
Date of birth:  26 July 1966 
Home address: Duinoordstraat 69, 2023 WC  Haarlem 
tel. +31-23-5263125; +31-6-10528453 (cell) 
jce.komen@planet.nl 
 
Main fields of expertise 
 
Research policy and strategy; Research management; International agricultural development; 
International technology transfer; Research capacity building; Policy and management 
aspects of new agricultural technologies. 
 
Education 
 
1990: MA degree Political Sciences, University of Amsterdam 
Main subject:  International Relations and Public International Law 
Main subsidiary: Development Economics 
Other subsidiaries: Economics, Contemporary History 
 
Recent work experience 
 
2004 – present:   Advisor on Biotechnology and Biosafety, Haarlem, The Netherlands. Main 
assignments: 
 International Food Policy Research Institute (IFPRI), Washington D.C., USA: Managing 
the planning and implementation of research and technical assistance activities under the 
Program for Biosafety Systems (PBS). PBS supports partner countries as they develop the 
policy and legal framework, administrative procedures, technically qualified personnel 
and outreach mechanisms integral to their national biosafety systems. Specific 
responsibilities for (i) implementing activities in PBS partner countries in sub-Sahara 
Africa and Southeast Asia; (ii) work plan development, technical progress and impact 
reports, monitoring and evaluation. Ongoing assignment. 
  Stockholm Environment Institute (SEI), Sweden: Work as external advisor on (a) 
Supporting planning and implementation of research and education activities on policy 
aspects of agricultural biotechnology, including biosafety and intellectual property 
management, under the BIO-EARN (Sweden – East Africa) program; (b) Contributing to 
the planning processes and implementation of policy activities defined for Phase III 
(2006-09) of BIO-EARN; (c) Reviewing proposals for competitive research grants; (d) 
Advising on new regional initiative, BioInnovate, starting 2010. BIO-EARN aims to build 
capacity in biotechnology in East Africa, and promote appropriate research and related 
policies. Ongoing assignment. 
 United Nations Environment Programme (UNEP), Switzerland: (i) Act as resource person 
in the planning and implementation of a regional biosafety implementation workshop in 
Tblisi, Georgia. Supported the development of Medium-Sized Projects (MSPs) for 
biosafety framework implementation in Georgia, Armenia, Moldova.  January 2005 
(completed); (ii) Develop an analysis and report of accomplishments and lessons learned 
from 8 UNEP-GEF demonstration projects on biosafety framework implementation. May 
2007 – April 2008 (completed); (iii) Conduct expert review and report (with Peter 
Morgan, consultant) on the Effectiveness of Various Approaches to Biosafety Capacity 
Building. February – September 2010 (completed). 
 Asian Development Bank (ADB) / AgriCo, New Zealand: Serve as Biosafety Policy 
Specialist for the ADB-supported “Strengthening Capacity and Regional Cooperation in 
Advanced Agricultural Science and Technology in the Greater Mekong Subregion 
Project”. Analyze implications of international biosafety agreements and guidelines, 
assess national capacities, and develop capacity development action plans for Cambodia, 
Laos, Thailand, Vietnam. October 2005 – January 2007 (completed). 
 
Selected, recent publications 
 
 (with Carliene Brenner, Rose Kingamkono, Julius Ecuru, Jane Omari, David Njubi, 
Hellen Opolot and Pantaleon Chuwa). 2010. Fostering Bioscience Innovation: Lessons 
from BIO-EARN. Synthesis chapter of a study on Innovation systems for Biotechnology 
in Kenya, Tanzania and Uganda, BIO-EARN, June 2010. 
 (with Rosemary Wolson, Elijah Ateka and Ivar Virgin). 2009. Analysis of the Potential 
for Value Addition and Product Development Partnership Opportunities Emerging from 
the BIO-EARN R4D Projects: Policy recommendations. Policy Brief No.2. Kampala: 
East African Regional Programme and Research Network for Biotechnology, Biosafety 
and Biotechnology Policy Development (BIO-EARN). 
 (with Idah Sithole-Niang). 2009. Regulatory Requirements and Technology Diffusion: 
The Case of Biotech Cotton. Paper presented at the technical seminar on “Biosafety 
Regulations, Implementation and Consumer Acceptance”, at the 68th plenary meeting of 
the International Cotton Advisory Committee. September 10, 2009, Cape Town, South 
Africa. 
 (with Catarina Cronquist). 2008. The Program for Biosafety Systems: Best Practices and 
Lessons Learned. Biosafety Protocol News, Vol.3, No.5 (December 2008), pp.12-14. 
 2008. Towards functional biosafety regulatory frameworks in sub-Sahara Africa: 
Achievements and lessons learned. Paper presented at the 1
st
 BIO-EARN/VicRes 
Scientific Conference, 24-27 November 2008, Kampala, Uganda. 
 (with Walter S. Alhassan, Catarina Cronquist, Alick Manda, Boniface Mkoko, Theresa 
Sengooba, Idah Sithole-Niang, David Wafula). 2008. Towards functional biosafety 
regulatory frameworks in Kenya, Uganda, Ghana and Malawi: Activities and 
 achievements under the Program for Biosafety Systems. Paper presented at the 1
st
 All 
Africa Biotechnology Congress, 22-26 September 2008, Nairobi, Kenya. 
 2008. Guidance towards Implementation of National Biosafety Frameworks: Lessons 
Learned from the UNEP Demonstration Projects. Report for the UNEP-GEF Biosafety 
Unit. Geneva: United Nations Environment Programme. 
 (with Ivar Virgin, Malur Bhagavan, Alois Kullaya, Niels Louwaars, E. Jane Morris, 
Patrick Okori and Gabrielle Persley). 2007. Agricultural Biotechnology and Small-scale 
Farmers in Eastern and Southern Africa. Stockholm: Stockholm Environment Institute. 
 
 
 
Shumu Teferra 
Ministry of Science & Technology 
Tel. 251-11 553 49 42, 0911- 22 88 19 
E-mail:- shumu_tefera@yahoo.com 
 
1. Educational Background 
2000 Post graduate course on Food Technology, Hebrew  University of Jerusalem, 
Israel.  
1979 Msc. In Food Processing Engineering, Krasnodar Polytechnic Institute, 
Krasnodar, former USSR.  
1980 Diploma in Animal production Technology, Awasa Junior College of 
Agriculture, Awassa, Ethiopia. 
 
2. Employment 
10/2007-10/2008 Deputy Director General, Ethiopian Science and Technology 
Agency. 
08/1997-10/2007 Head, Industry Department, Ethiopian Science and Technology 
Commission (ESTC). 
 07/1994-07/1997  Team leader & Acting Head, Industry Department, 
(ESTC).  
06/1993-06/1994 Senior Expert, Handicrafts and Small Industries Technology, 
ESTC. 
 11/1987-05/1993  Expert, Industry and Technology Research Council, 
ESTC. 
08/1980-12/1981 Assistant Head, Addis Ababa Milk Processing Plant, Dairy 
Development Enterprise, Addis Ababa. 
 
3. Institutional Governance Leadership Positions 
2008 - present  Chairman, Scientific Equipment Centre Board. 
2001 - 2009  Board Member, Fafa Food Share Company. 
2001 - 2006  Board Member, Repi Soap Factory. 
1998 - 2001  Board Member, Productivity Improvement Centre. 
 
 
4. Professional Career 
2006-2008 National coordinator, Biotechnology and Bio-safety for East African 
Research Network (BIO-EARN) of the policy Pogramme.  
2000-2004 Deputy Director, Ethiopian Cleaner Production Centre. 
1994-2007 Secretary of the National Industrial Science & Technology Council  
 1997 National Project Coordinator, „‟50 Innovative and Successful Industrial 
Enterprises in Africa‟‟ UNIDO Programme.  
1993-1997  Sub-programme coordinator of the „‟Science & Technology Access 
and Application‟‟ of the 5th cycle Human Resource Development & 
Utilization  (HRDU) country programme funded by UNDP.  
 
5. Participation in Professional Association 
Member of the Ethiopian Chemical Engineers Society 
 
 
 
JANE BISIERI OMARI 
Contact Address: National Council For Science and Technology 
  Utalii Lane, off Utalii Street 
  PO Box 30623-00100 
Nairobi  
Kenya 
Tel +254 20 2219420/336173/4/5 cell +254 720 574 668 
 
Current Position: Senior Science Secretary in Agriculture and Allied Sciences 
Responsibilities: Policy Advise to Government on Scientific and Technological Development 
in Agriculture & Related Sciences. Organize & Coordinate meetings and workshops for 
Council activities related to agricultural science. 
Co-PI for Project 5 in Phase 3 of BIOEARN Program in charge of project implementation, 
financial management and report preparation. We offered policy support and successfully 
established IP offices in BIOEARN member‟s institution in Kenyatta, Moi, JKUAT 
Universities and at Kenya Agricultural Research Institute.   
Participated as task force member in formulation of The „National Agricultural Research 
Systems Policy‟, National Biotechnology Development Strategy and National Biosafety Bill 
 
Educational Background 
Kenyatta University, Nairobi Kenya MSC Zoology (1992)  
Kenyatta University, Nairobi Kenya, BED Botany, Zoology, Education (1986)  
 
Recent Selected Short Courses 
1. Senior Management Course , Kenya Institute of Administration 18thJanuary -12th 
February 2010 
2. „Environmental Biosafety Short Course‟. Michigan State University. Institute of 
International Agriculture, USA. August 9-14
th
 2009. 
3. „Financial Management and Reporting Trainings‟, organized by the Interuniversity 
Council for East Africa  Entebbe Uganda14th-16
th
 April 2008 
4. Corporate Governance‟ Five day training Course for Directors‟ Mombasa Serena 
Hotel 2007. 
5. Several short courses on „Biotechnology and Biosafety Policy Analysis” at Institute of 
Science and Technology Policy Analysis between 2005-2009 
 
 Selected recent policy reports in proceedings  
 
Omari J. 2010. „Turning Research into Use: The Policy Brief‟ paper presented at the 5th  
Annual International Conference, Egerton Njoro September 2010 
 Brenner, C., J. Komen, R. Kingamkono, J. Ecuru, J. Omari, D. Njubi, H. Opolot, and P. 
Chuwa. 2010. Fostering Bioscience Innovation: Lessons from BIO-EARN. Kampala, 
Uganda: East Africa Regional Programme and Research Network for Biotechnology, 
Biosafety and Biotechnology Policy Development.  
Omari, J and Njubi D. 2010. „The Biotechnology Innovation System in Kenya‟. The case of 
BIOEARN. Paper presented at the 3
rd
 Annual Scientific Conference for dissemination 
of Research Results. Kenyatta International Conference Centre, Nairobi ,Kenya 
Omari J. 2009. „Managing Intellectual Property in Research Collaborations at the 
Universities and Research Institutions in Eastern Africa‟. Paper presented at the 
Annual Science Week and International Conference. Moi University Eldoret, Kenya  
Omari J. 2009. „Opportunities in BIOEARN Research for Development  Projects in Kenya ‟. 
Key note presentation at the fourth Research week and International Conference, 
Egerton University, Njoro, Kenya  
Omari J. B., Kingamkono R.R., Ecuru J., Shumu., “Product Development Partnership 
opportunities in the BIOEARN Research & Development Projects: Paper presented at 
the BIOEARN/VICRES Scientific Conference at Speke Resort Munyonyo 24
th
 – 26th 
November 2008 
Omari J.B., Ecuru J., Kingamkono R., and Mugiira R.B., „Building Capacity for Intelectual 
Property Management in Biotechnology products in East AfricaPaper presented at the 
1
st
 All African Congress on Biotechnology at The Grand Regency (now Laico) on 
22
nd
 – 26th September 2008. 
 Curriculum vitae for Marie-Christine Gasingirwa 
 
Date of birth : 12-June-1952 
Place of birth: Gahini- Rwanda 
Nationality : Rwandan 
Marital status : Single 
Address : The Ministry of Education 
                 Directorate of Science, Technology and Research, 
                 P. O. Box 622 
                 KIGALI-RWANDA 
 
                 Telephone: GSM +250 785 068 350 
                  E-mail : cgasingirwa@nur.ac.rw, mariechristine_gasingirwa@yahoo.co.uk. 
 
Education  and professional information : 
A. Education : 
Year                                           Awards 
2003- 2009 
1999- 2001 
1976-1979 
1973- 1976 
1970- 1971 
1967- 1969 
PhD in Biomedical  and Pharmaceutical Sciences: Namur, Belgium 
MSc. In Agricultural Biotechnology, West Texas A&M, USA 
BSc.  In Zoology and Biochemistry, University of Nairobi, Kenya. 
(SI) Certificate, (Biology-Chemistry), Kenya Science Teachers College, 
Kenya. 
EAACE, Gayaza High School, Kampala, Uganda. 
EAC? Nyakasura School, Fort-Portal, Uganda. 
B. Work Experiences: 
Year                                         Locality 
1979- 1984 
1984- 1992 
1992- 1994 
1994- 1995 
1995- 1999 
May2009-Oct 
2009 
 
Oct 2009- To 
date 
Graduate Teacher  at the Kenya Science Teachers College, Nairobi, Kenya 
Graduate teacher at the Kianda High School, Nairobi, Kenya 
Graduate Teacher at the Agha Khan Academy, Nairobi, Kenya 
Civil servant at the Ministry of Education, Kigali, Rwanda 
Assistant Lecturer at the National University (NUR), Butare, Rwanda 
Senior Lecturer at the NUR, Butare, Rwanda (Medicine lecturing in 
Cellular and Molecular Biology as well as  Biochemistry).  
 
Director General for Science, technology and Research, ministry of 
Education 
Seminars and Workshops                     
   
 Since  Mid-October 2009-Date: Director General for Science, Technology and Research in 
the  
            Ministry of Education. From where I have attended many conferences and workshops  
            both international and national representing Rwanda: 
           Organised and participated in the Workshop on Tropical Rift Lake Systems: Integrated  
           Volcanologic, Tectonic, and Biogeochemical, and Geohazard Assessment of Lake 
            Kivu, Rubavu/ Gisenyi, Rwanda, January 13
th
 – 15th , 2010. 
- Organized and participated in the „Unlocking the potential of Science, Technology 
and Innovation to achieve the MDGs in Rwanda‟, Serena Hotel, Kigali, 21st – 22 nd 
January 2010. 
 - Participated as a Member of the Technical Team that prepared the meeting for 
ministers in charge of Higher Education for CEPGL Member States, held in 
Bujumbura, Burundi, on the 25
th
-30
th
  January 2010. 
- Participated and presented a paper in the Conference on „Food Fortification and 
Nutrition Solutions for Community Health In Rwanda‟, organised by the University 
of Illinois, Serena Hotel , Kigali, on the 3rd-4th, February 2010. 
- Participated in the Workshop on Commercialising African Health Research through 
Life Science innovation Platforms, sponsored by the McLaughlin-Rotman Centre for 
Global Health, 12
th
 -13
th
  February, 2010. 
- Participated in the 4th African Ministerial Conference on Science and Technology 
(IV
th
 AMCOST), held in Cairo-Egypt, March 6
th
-10
th
, 2010.  
- Participated in the 2010 Network for the Coordination and Advancement of Sub-
Saharan Africa-EU Science and Technology Coordination (CAAST-Net), chairing    
The Stakeholder meeting session on „CAAST-Net Thematic Presentations, 16th-18th 
May 2010, Durban, South Africa. 
- As a member of the Assessment Team appointed by the GoR to identify how to 
develop Rwanda‟s position in CEPGL, by a study tour to the three Member States, 
visiting the  CEPGL and its Specialized institutions, 26
th
 May-5
th
 June 2010. 
- Took part as a Member of Technical Team of Experts that presented findings of the 
above survey in preparation for the CEPGL Council of Ministers, in Rubavu, on the 
26
th
  -30
th
 July 2010. 
- Took part in the National Workshop on Biosafety Policies and Guidelines, organized 
by REMA (Rwanda Environment Management Authority) in partnership with 
Common Market in Eastern and South  Africa (COMESA), the Association for 
strengthening Agricultural Research in Eastern and Central Africa (ASARECA), the 
Programme for Biosafety System (PBS), the Alliance for Commodity Trade in 
Eastern Africa (ECTESA) and  the International Service for the Acquisition of the 
Agri-Biotech Applications (ISAAA) in  Kigali,  on the 21-22 September, Laico Hotel.  
        -  Organized and participated in the Regional Integration and Human Resources  
            Development in Science and Technology Fields” Conference  held on the  8th  
            and 9
th
 December 2010 as collaboration between the International Office of the 
AAAS  
            (American Association for Advancement of Science) and the Government of 
Rwanda”  
         -  Dec 13th-16
th
 2010 took part in the Consultative Workshop on the Centre of   
            Excellence  on Biodiversity and Natural Resources Management for Rwanda,  
- 7th-9th Feb, 2011, took part and presented a paper on Research Regulation in Rwanda 
at the Lake Kivu Monitoring Workshop, Serena Hotel-Rubavu. 
- 23rd-25th March, 2011, took part in the Development Partners Meeting at Serena 
Hotel-Rubavu, as a Member of  the Government of Rwanda delegation. 
- Participated in the Regional Training on Reinforcement of National Capacities in STI 
and Statistics Indicators of STI in Central Africa organized by UNESCO- Libreville, 
Gabon on 12
th
  -15
th
 April 2011. 
      -    Participated at the „Agricultural Biotechnology in Africa: Fostering Innovation‟in  
           Addis Ababa, Ethiopia May 13
th
- 15
th 
2011, at the United Nations Conference Centre a  
           co-hosted by both the AIA project  and the Addis Ababa University. 
 
NB:  I took part in many national workshops and seminars in relation to education in    
        general and Science and Technology in Education in particular. 
 By virtue of my position in the Ministry of Education, I serve as a Member of a number of 
Committees, such as the Inter-University Council of East Africa, Committee on for the 
selection of eligible candidates for Cambridge Commonwealth Trust Scholarship Committee 
(Rwanda Chapter), Committee for the establishment of centres of Excellence in ICT and 
Biodiversity, etc… Moreover, I often assume interim duties during the absence of the 
Permanent Secretary.        
Poster presentation: (1) at Autumn Meeting 2005 of the BSCDB, Saturday 15
th 
October  
     2005 Universiteit Hasselt, Campus Diepenbeek, Agoralaan, Bldg. D, BE-3590 
     Diepenbeek NEUROGLIA. „Hyal-1 in liver, is it an authentic lysosomal hydrolase?‟ 
     Gasingirwa M-C, Thirion J, Mertens-Strijthagen J, Patel N, Triggs-Raine B,  
     Flamion B, and Jadot M.   
                             (2) at the ASBMB Conference in San Fransisco, December 2008. Is   
    Hyal-1 an authentic lysosomal protein ? M. Gasingirwa, J. Thirion, B. Flamion, R.  
    Wattiaux, M. Jadot.  
Publications :  
- Robert Wattiaux, Simone Wattiaux-De Coninck, Jacqueline Thirion, Marie-
Christine Gasingirwa, and Michel Jadot (2007). Lysosomes and Fas mediated liver 
cell death. Biochem J; 403: 89–95.  
- Gasingirwa M.C, Thirion J., Costa C, Flamion F., Lobel P., and Jadot M. (2008). A  
      method to assess the lysosomal residence of proteins in cultured cells. Anal Biochem   
      374 : 31–40.  
- Thesis: Is Hyal-1 an Authentic Lysosomal Enzyme? Defended on the 12 May 2009,  
      for an award of „Docteur en Sciences Biomedicales et Pharmaceutiques‟. 
- Gasingirwa M.C, Thirion J., Jeannine Mertens Strijthagen, Wattiaux-De Coninck 
Simone, Flamion B., Wattiaux R.and Jadot M. (2010).  Endocytosis of 
Hyaluronidase-1 by the Liver. Biochem. J., 430, 305-313 . 
Other awards include : 
 
1. 2
nd
 August 1976, Diplôme de la Langue Française- Alliance Française- Nairobi, Kenya. 
2. June 26
th
-July 1994: Certificate on Conservation Education by Elsamere Conservation  
    Trust- Naivasha- Kenya. 
3.  March 30
th
-3
rd
 April 1998 : First Regional Training Workshop on Development and 
Negotiation of  
     Partnership Proposals in Kampala-Uganda (African Science & Technology Exchange -
ASTEX). 
4. Holder of a certificate on General Radiation Safety Training presented by the 
Environmental Health  
     and Safety Department of Texas A&M University. (27
th
 March, 2001), USA. 
 5. „Certificat Universitaire Complémentaire en Science des Animaux de Laboratoire‟  
(Université  
     Libre de Bruxelles –ULB, 2005-2006- Belgium).  
6. Participated in the annual „Biosecurité, Radioprotection et Gestion des risques chimiques‟, 
2005, 
    2006, 2007, 2008 and 2009 at the FUNDP (Facultés Universitaires Notre Dame de la Paix, 
Namur-  
    Belgium         
Language knowledge: 
 
1. Kinyarwanda- written and spoken (fluently) 
2. English         - written and spoken (fluently) 
 3. French          - written and spoken (fairly well) 
4. Kiswahili      - spoken (fluently) 
 
Done in Kigali, 19
th
 May 2011. 
 
Gasingirwa Marie-Christine (Ph D)  
 
 
 
Curriculum vitae for Pantaleon Casmir Chuwa 
Surname: CHUWA 
Other names: Pantaleon Casmir 
Gender: Male 
Nationality: Tanzanian 
Date of Birth: 2
nd
 September 1954 
Address: Tanzania Commission for Science and Technology (COSTECH) 
  P.O. Box 4302 DAR ES SALAAM – TANZANIA 
Telephone: 255 (0) 783 183080 
Email:  pchuwa@costech.or.tz   pantachuwa@yahoo.co.uk 
 
Employer: Tanzania Commission for Science and Technology (COSTECH), Dar es 
Salaam. 
Designation: Senior Research Officer 
 
Education: 
Name, place and 
Country 
Attended from/To Degree 
awarded 
Main course of 
 study 
Lund University, 
Sweden 
Aug. 1999 – June 
2000 
Master of 
Science 
Ecology (Biosafety) 
University of Dar es 
Salaam, Tanzania 
May 1994 – Dec. 
1996 
Master of 
Science 
Applied Microbiology 
(Environment 
Management) 
University of Dar es 
Salaam, Tanzania 
Sept. 1989 – May 
1993 
Bachelor of 
Science 
Applied Microbiology  
Livestock Training 
Institute, Morogoro -
Tanzania 
Jan1981 – Dec. 
1982 
Diploma Pest control 
IAEA Seibersdorf 
Laboratories, 
Vienna – Austria 
March - July. 1989  Certificate Pest control 
using radiation  
 
Employment and Experience: 
Employed as Senior Research Officer by the Tanzania Commission for Science and 
Technology (COSTECH), Dar es Salaam - Tanzania since November 1997 to date, working 
as a Programme Officer-Biosafety and Biotechnology, responsible for the following:  
 Servicing the National Biotechnology Advisory Committee (NBAC); 
  Reviewing and formulation of national biotechnology and biosafety related policies; 
 project/ programme development, monitoring and evaluation activities related to 
biotechnology; 
 organization of workshops for government policy and decision makers on consensus 
making on matters pertaining to national, regional and international agreements in 
biotechnology;  
 Secretariat to the national, regional and international collaborative initiatives on 
biosafety and biotechnology programmes; and 
 Team member during implementation of Project 5 under BIO-EARN programme 
which ended last year (2010) on “Enhancing Product Development Opportunities and 
Supportive Policies”. All planned activities were implemented successfully and 
produced reports, proceedings and policy briefs for evidence-informed decisions 
among policy makers and other stakeholders at national and regional levels.    
 
